CN101535499B - 点护理流体系统及其应用 - Google Patents
点护理流体系统及其应用 Download PDFInfo
- Publication number
- CN101535499B CN101535499B CN200680024658.XA CN200680024658A CN101535499B CN 101535499 B CN101535499 B CN 101535499B CN 200680024658 A CN200680024658 A CN 200680024658A CN 101535499 B CN101535499 B CN 101535499B
- Authority
- CN
- China
- Prior art keywords
- fluid means
- systems
- sample
- analyte
- fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 claims abstract description 208
- 239000012530 fluid Substances 0.000 claims description 319
- 239000012491 analyte Substances 0.000 claims description 182
- 238000004458 analytical method Methods 0.000 claims description 137
- 238000006243 chemical reaction Methods 0.000 claims description 112
- 239000003153 chemical reaction reagent Substances 0.000 claims description 103
- 238000001514 detection method Methods 0.000 claims description 88
- 239000003814 drug Substances 0.000 claims description 81
- 230000008859 change Effects 0.000 claims description 53
- 238000004891 communication Methods 0.000 claims description 51
- 238000011282 treatment Methods 0.000 claims description 47
- 239000000376 reactant Substances 0.000 claims description 41
- 210000001124 body fluid Anatomy 0.000 claims description 40
- 239000010839 body fluid Substances 0.000 claims description 40
- 230000000694 effects Effects 0.000 claims description 40
- 230000000144 pharmacologic effect Effects 0.000 claims description 38
- 238000003018 immunoassay Methods 0.000 claims description 35
- 238000012360 testing method Methods 0.000 claims description 35
- 238000010324 immunological assay Methods 0.000 claims description 34
- 239000003795 chemical substances by application Substances 0.000 claims description 33
- 239000000463 material Substances 0.000 claims description 31
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 27
- 201000010099 disease Diseases 0.000 claims description 25
- 239000002585 base Substances 0.000 claims description 24
- 229940079593 drug Drugs 0.000 claims description 23
- 230000005540 biological transmission Effects 0.000 claims description 22
- 239000000090 biomarker Substances 0.000 claims description 21
- 238000012544 monitoring process Methods 0.000 claims description 19
- 229940124597 therapeutic agent Drugs 0.000 claims description 19
- -1 S-100 albumen Proteins 0.000 claims description 16
- 239000003513 alkali Substances 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 14
- 230000001225 therapeutic effect Effects 0.000 claims description 14
- 238000012545 processing Methods 0.000 claims description 13
- 239000003550 marker Substances 0.000 claims description 12
- 102000039446 nucleic acids Human genes 0.000 claims description 12
- 108020004707 nucleic acids Proteins 0.000 claims description 12
- 150000007523 nucleic acids Chemical class 0.000 claims description 12
- 239000002207 metabolite Substances 0.000 claims description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 10
- 231100000419 toxicity Toxicity 0.000 claims description 10
- 230000001988 toxicity Effects 0.000 claims description 10
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims description 9
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims description 9
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 7
- 210000004185 liver Anatomy 0.000 claims description 6
- 108010088751 Albumins Proteins 0.000 claims description 5
- 230000001413 cellular effect Effects 0.000 claims description 5
- 239000002359 drug metabolite Substances 0.000 claims description 5
- 150000002632 lipids Chemical class 0.000 claims description 5
- 229920001184 polypeptide Polymers 0.000 claims description 5
- 102000029752 retinol binding Human genes 0.000 claims description 5
- 108091000053 retinol binding Proteins 0.000 claims description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 claims description 4
- 102000030914 Fatty Acid-Binding Human genes 0.000 claims description 4
- 102000003886 Glycoproteins Human genes 0.000 claims description 4
- 108090000288 Glycoproteins Proteins 0.000 claims description 4
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 claims description 4
- 238000011156 evaluation Methods 0.000 claims description 4
- 108091022862 fatty acid binding Proteins 0.000 claims description 4
- 150000004676 glycans Chemical class 0.000 claims description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 4
- 229920001282 polysaccharide Polymers 0.000 claims description 4
- 239000005017 polysaccharide Substances 0.000 claims description 4
- 210000002700 urine Anatomy 0.000 claims description 4
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 claims description 3
- 108010082126 Alanine transaminase Proteins 0.000 claims description 3
- 102100028892 Cardiotrophin-1 Human genes 0.000 claims description 3
- 102000012192 Cystatin C Human genes 0.000 claims description 3
- 108010061642 Cystatin C Proteins 0.000 claims description 3
- 108010049003 Fibrinogen Proteins 0.000 claims description 3
- 102000008946 Fibrinogen Human genes 0.000 claims description 3
- 108010062374 Myoglobin Proteins 0.000 claims description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 3
- 102000008080 Pancreatitis-Associated Proteins Human genes 0.000 claims description 3
- 108010074467 Pancreatitis-Associated Proteins Proteins 0.000 claims description 3
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 claims description 3
- 108010004408 TRPP Cation Channels Proteins 0.000 claims description 3
- 108010065729 Troponin I Proteins 0.000 claims description 3
- 241000700605 Viruses Species 0.000 claims description 3
- 230000000844 anti-bacterial effect Effects 0.000 claims description 3
- 108010041776 cardiotrophin 1 Proteins 0.000 claims description 3
- 229940012952 fibrinogen Drugs 0.000 claims description 3
- 235000008434 ginseng Nutrition 0.000 claims description 3
- 108010023015 ischemia-modified albumin Proteins 0.000 claims description 3
- 230000007246 mechanism Effects 0.000 claims description 3
- 244000005700 microbiome Species 0.000 claims description 3
- 108010065887 myosin light chain I Proteins 0.000 claims description 3
- 102000013415 peroxidase activity proteins Human genes 0.000 claims description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 3
- 230000003285 pharmacodynamic effect Effects 0.000 claims description 3
- 150000003180 prostaglandins Chemical class 0.000 claims description 3
- 239000002423 protozoacide Substances 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims description 3
- 102000004400 Aminopeptidases Human genes 0.000 claims description 2
- 108090000915 Aminopeptidases Proteins 0.000 claims description 2
- 239000004382 Amylase Substances 0.000 claims description 2
- 102000013142 Amylases Human genes 0.000 claims description 2
- 108010065511 Amylases Proteins 0.000 claims description 2
- 101800000407 Brain natriuretic peptide 32 Proteins 0.000 claims description 2
- 102400000667 Brain natriuretic peptide 32 Human genes 0.000 claims description 2
- 101800002247 Brain natriuretic peptide 45 Proteins 0.000 claims description 2
- 102100035023 Carboxypeptidase B2 Human genes 0.000 claims description 2
- 108090000201 Carboxypeptidase B2 Proteins 0.000 claims description 2
- 101710088194 Dehydrogenase Proteins 0.000 claims description 2
- 241000233866 Fungi Species 0.000 claims description 2
- 102000007390 Glycogen Phosphorylase Human genes 0.000 claims description 2
- 108010046163 Glycogen Phosphorylase Proteins 0.000 claims description 2
- 101000752037 Homo sapiens Arginase-1 Proteins 0.000 claims description 2
- 101000800287 Homo sapiens Tubulointerstitial nephritis antigen-like Proteins 0.000 claims description 2
- 108010044467 Isoenzymes Proteins 0.000 claims description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 2
- 102000003960 Ligases Human genes 0.000 claims description 2
- 108090000364 Ligases Proteins 0.000 claims description 2
- 102400001263 NT-proBNP Human genes 0.000 claims description 2
- 108700022034 Opsonin Proteins Proteins 0.000 claims description 2
- 108030001694 Pappalysin-1 Proteins 0.000 claims description 2
- 102000005819 Pregnancy-Associated Plasma Protein-A Human genes 0.000 claims description 2
- 108090000190 Thrombin Proteins 0.000 claims description 2
- 235000004279 alanine Nutrition 0.000 claims description 2
- 235000019418 amylase Nutrition 0.000 claims description 2
- 229940049370 fibrinolysis inhibitor Drugs 0.000 claims description 2
- 239000012634 fragment Substances 0.000 claims description 2
- 239000002874 hemostatic agent Substances 0.000 claims description 2
- 239000004310 lactic acid Substances 0.000 claims description 2
- 235000014655 lactic acid Nutrition 0.000 claims description 2
- 108010008064 pro-brain natriuretic peptide (1-76) Proteins 0.000 claims description 2
- 229960004072 thrombin Drugs 0.000 claims description 2
- 241000208340 Araliaceae Species 0.000 claims 2
- 102000003896 Myeloperoxidases Human genes 0.000 claims 2
- 108090000235 Myeloperoxidases Proteins 0.000 claims 2
- KINMYBBFQRSVLL-UHFFFAOYSA-N 4-(4-phenoxybutoxy)furo[3,2-g]chromen-7-one Chemical compound C1=2C=COC=2C=C2OC(=O)C=CC2=C1OCCCCOC1=CC=CC=C1 KINMYBBFQRSVLL-UHFFFAOYSA-N 0.000 claims 1
- 102100027211 Albumin Human genes 0.000 claims 1
- 102100021723 Arginase-1 Human genes 0.000 claims 1
- 101100226596 Gallus gallus FABP gene Proteins 0.000 claims 1
- 102000004366 Glucosidases Human genes 0.000 claims 1
- 108010056771 Glucosidases Proteins 0.000 claims 1
- 101001104199 Homo sapiens Retinitis pigmentosa 9 protein Proteins 0.000 claims 1
- 101001104198 Mus musculus Retinitis pigmentosa 9 protein homolog Proteins 0.000 claims 1
- 102000036675 Myoglobin Human genes 0.000 claims 1
- 102100040073 Retinitis pigmentosa 9 protein Human genes 0.000 claims 1
- 108700012920 TNF Proteins 0.000 claims 1
- 102100036860 Troponin T, slow skeletal muscle Human genes 0.000 claims 1
- 101710138875 Troponin T, slow skeletal muscle Proteins 0.000 claims 1
- 239000010808 liquid waste Substances 0.000 claims 1
- 238000007086 side reaction Methods 0.000 claims 1
- 239000013060 biological fluid Substances 0.000 abstract description 7
- 238000011897 real-time detection Methods 0.000 abstract description 4
- 238000012123 point-of-care testing Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 227
- 239000007788 liquid Substances 0.000 description 49
- 239000008280 blood Substances 0.000 description 34
- 230000008569 process Effects 0.000 description 34
- 210000004369 blood Anatomy 0.000 description 32
- 102000004190 Enzymes Human genes 0.000 description 24
- 108090000790 Enzymes Proteins 0.000 description 24
- 230000009471 action Effects 0.000 description 24
- 229940088598 enzyme Drugs 0.000 description 24
- 238000010348 incorporation Methods 0.000 description 22
- 238000004519 manufacturing process Methods 0.000 description 20
- 239000000758 substrate Substances 0.000 description 20
- 150000001875 compounds Chemical class 0.000 description 18
- 238000005259 measurement Methods 0.000 description 18
- 230000008901 benefit Effects 0.000 description 17
- 238000000354 decomposition reaction Methods 0.000 description 16
- 238000005516 engineering process Methods 0.000 description 16
- 239000000203 mixture Substances 0.000 description 15
- 210000002381 plasma Anatomy 0.000 description 15
- 108090000623 proteins and genes Proteins 0.000 description 15
- 238000003860 storage Methods 0.000 description 15
- 239000002699 waste material Substances 0.000 description 15
- 235000018102 proteins Nutrition 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 14
- 230000035945 sensitivity Effects 0.000 description 14
- 239000000872 buffer Substances 0.000 description 12
- 238000013461 design Methods 0.000 description 12
- 238000002156 mixing Methods 0.000 description 12
- 238000011160 research Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 238000002372 labelling Methods 0.000 description 11
- 108091006146 Channels Proteins 0.000 description 10
- 238000010171 animal model Methods 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 230000000474 nursing effect Effects 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 230000003287 optical effect Effects 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 230000004044 response Effects 0.000 description 9
- 238000004364 calculation method Methods 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 230000032258 transport Effects 0.000 description 8
- 206010003805 Autism Diseases 0.000 description 7
- 208000020706 Autistic disease Diseases 0.000 description 7
- 238000004422 calculation algorithm Methods 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 230000007704 transition Effects 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- 239000000427 antigen Substances 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- 230000009137 competitive binding Effects 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 238000011049 filling Methods 0.000 description 6
- 230000003834 intracellular effect Effects 0.000 description 6
- 238000004020 luminiscence type Methods 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 238000007789 sealing Methods 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 231100001274 therapeutic index Toxicity 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 241000222122 Candida albicans Species 0.000 description 5
- 241000194032 Enterococcus faecalis Species 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 238000000429 assembly Methods 0.000 description 5
- 230000000712 assembly Effects 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 230000027455 binding Effects 0.000 description 5
- 229940095731 candida albicans Drugs 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 239000003599 detergent Substances 0.000 description 5
- 231100000673 dose–response relationship Toxicity 0.000 description 5
- 238000002651 drug therapy Methods 0.000 description 5
- 229940032049 enterococcus faecalis Drugs 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- 238000005070 sampling Methods 0.000 description 5
- 229910052710 silicon Inorganic materials 0.000 description 5
- 238000012421 spiking Methods 0.000 description 5
- 102400000630 Acylation stimulating protein Human genes 0.000 description 4
- 101800000415 Acylation stimulating protein Proteins 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 4
- 102100023635 Alpha-fetoprotein Human genes 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 108010014172 Factor V Proteins 0.000 description 4
- 108010074864 Factor XI Proteins 0.000 description 4
- 102100037765 Periostin Human genes 0.000 description 4
- 101710199268 Periostin Proteins 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- 108010072866 Prostate-Specific Antigen Proteins 0.000 description 4
- 102100038358 Prostate-specific antigen Human genes 0.000 description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 238000011088 calibration curve Methods 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 239000004020 conductor Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000003722 extracellular fluid Anatomy 0.000 description 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 238000007747 plating Methods 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000010703 silicon Substances 0.000 description 4
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 4
- 102000004379 Adrenomedullin Human genes 0.000 description 3
- 101800004616 Adrenomedullin Proteins 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 3
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- 108090000368 Fibroblast growth factor 8 Proteins 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 102000016267 Leptin Human genes 0.000 description 3
- 108010092277 Leptin Proteins 0.000 description 3
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 241000191940 Staphylococcus Species 0.000 description 3
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 238000005415 bioluminescence Methods 0.000 description 3
- 230000029918 bioluminescence Effects 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 238000005336 cracking Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000005281 excited state Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- 230000004907 flux Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 3
- 230000009474 immediate action Effects 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 229940039781 leptin Drugs 0.000 description 3
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229960003085 meticillin Drugs 0.000 description 3
- 238000005459 micromachining Methods 0.000 description 3
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 102000005162 pleiotrophin Human genes 0.000 description 3
- 210000002307 prostate Anatomy 0.000 description 3
- 239000004065 semiconductor Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 238000004611 spectroscopical analysis Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 2
- 102000013563 Acid Phosphatase Human genes 0.000 description 2
- 108010051457 Acid Phosphatase Proteins 0.000 description 2
- 102100031786 Adiponectin Human genes 0.000 description 2
- 108010076365 Adiponectin Proteins 0.000 description 2
- 206010061623 Adverse drug reaction Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 102100025674 Angiopoietin-related protein 4 Human genes 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 101100496968 Caenorhabditis elegans ctc-1 gene Proteins 0.000 description 2
- 241000606161 Chlamydia Species 0.000 description 2
- 102100022641 Coagulation factor IX Human genes 0.000 description 2
- 102100030563 Coagulation factor XI Human genes 0.000 description 2
- 241001478240 Coccus Species 0.000 description 2
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 2
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 2
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 2
- 102100031939 Erythropoietin Human genes 0.000 description 2
- 108010076282 Factor IX Proteins 0.000 description 2
- 108010014173 Factor X Proteins 0.000 description 2
- 102100030431 Fatty acid-binding protein, adipocyte Human genes 0.000 description 2
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 241000606790 Haemophilus Species 0.000 description 2
- 101001034652 Homo sapiens Insulin-like growth factor 1 receptor Proteins 0.000 description 2
- 101001013832 Homo sapiens Mitochondrial peptide methionine sulfoxide reductase Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 102000013463 Immunoglobulin Light Chains Human genes 0.000 description 2
- 108010065825 Immunoglobulin Light Chains Proteins 0.000 description 2
- 206010061216 Infarction Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 description 2
- 241000588748 Klebsiella Species 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 241000589242 Legionella pneumophila Species 0.000 description 2
- 102100031775 Leptin receptor Human genes 0.000 description 2
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 102100030335 Midkine Human genes 0.000 description 2
- 108010092801 Midkine Proteins 0.000 description 2
- 102100031767 Mitochondrial peptide methionine sulfoxide reductase Human genes 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- 102100030856 Myoglobin Human genes 0.000 description 2
- 241000588653 Neisseria Species 0.000 description 2
- 101100221647 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cox-1 gene Proteins 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 241001597008 Nomeidae Species 0.000 description 2
- 102000008108 Osteoprotegerin Human genes 0.000 description 2
- 108010035042 Osteoprotegerin Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 101150062589 PTGS1 gene Proteins 0.000 description 2
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 2
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 2
- 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 description 2
- 102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 description 2
- 108010051742 Platelet-Derived Growth Factor beta Receptor Proteins 0.000 description 2
- 102000018967 Platelet-Derived Growth Factor beta Receptor Human genes 0.000 description 2
- 241000233872 Pneumocystis carinii Species 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 2
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241001147736 Staphylococcus capitis Species 0.000 description 2
- 241000192087 Staphylococcus hominis Species 0.000 description 2
- 241000192086 Staphylococcus warneri Species 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- 241000193996 Streptococcus pyogenes Species 0.000 description 2
- 108010000499 Thromboplastin Proteins 0.000 description 2
- 102000002262 Thromboplastin Human genes 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 description 2
- 241000606834 [Haemophilus] ducreyi Species 0.000 description 2
- ULCUCJFASIJEOE-NPECTJMMSA-N adrenomedullin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)N[C@@H]1C(N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)[C@@H](C)O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 ULCUCJFASIJEOE-NPECTJMMSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- FQCKMBLVYCEXJB-MNSAWQCASA-L atorvastatin calcium Chemical compound [Ca+2].C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC([O-])=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1.C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC([O-])=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 FQCKMBLVYCEXJB-MNSAWQCASA-L 0.000 description 2
- 239000005441 aurora Substances 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 125000002619 bicyclic group Chemical group 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000002771 cell marker Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000005229 chemical vapour deposition Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 229940121657 clinical drug Drugs 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 2
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229960000905 indomethacin Drugs 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000007574 infarction Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 229940115932 legionella pneumophila Drugs 0.000 description 2
- 108010019813 leptin receptors Proteins 0.000 description 2
- 229940002661 lipitor Drugs 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 238000004377 microelectronic Methods 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 230000002969 morbid Effects 0.000 description 2
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- XXUPLYBCNPLTIW-UHFFFAOYSA-N octadec-7-ynoic acid Chemical compound CCCCCCCCCCC#CCCCCCC(O)=O XXUPLYBCNPLTIW-UHFFFAOYSA-N 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 150000003901 oxalic acid esters Chemical class 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000008177 pharmaceutical agent Substances 0.000 description 2
- 230000002974 pharmacogenomic effect Effects 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 150000003815 prostacyclins Chemical class 0.000 description 2
- 239000012744 reinforcing agent Substances 0.000 description 2
- RZJQGNCSTQAWON-UHFFFAOYSA-N rofecoxib Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=C(C=2C=CC=CC=2)C(=O)OC1 RZJQGNCSTQAWON-UHFFFAOYSA-N 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 229960000278 theophylline Drugs 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- XNRNNGPBEPRNAR-JQBLCGNGSA-N thromboxane B2 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1OC(O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O XNRNNGPBEPRNAR-JQBLCGNGSA-N 0.000 description 2
- 150000003595 thromboxanes Chemical class 0.000 description 2
- 229940087652 vioxx Drugs 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- URJOZSLMTIRWFW-QGZVFWFLSA-N (4r)-4-(1,3-benzodioxol-5-yl)-5,6-dimethoxy-4,9-dihydro-1h-benzo[f][2]benzofuran-3-one Chemical compound C1=C2OCOC2=CC([C@H]2C3=C(COC3=O)CC3=CC=C(C(=C32)OC)OC)=C1 URJOZSLMTIRWFW-QGZVFWFLSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- BQCIDUSAKPWEOX-UHFFFAOYSA-N 1,1-Difluoroethene Chemical compound FC(F)=C BQCIDUSAKPWEOX-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- RNIPJYFZGXJSDD-UHFFFAOYSA-N 2,4,5-triphenyl-1h-imidazole Chemical group C1=CC=CC=C1C1=NC(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)N1 RNIPJYFZGXJSDD-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 description 1
- 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 description 1
- LVRVABPNVHYXRT-BQWXUCBYSA-N 52906-92-0 Chemical compound C([C@H](N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)C(C)C)C1=CC=CC=C1 LVRVABPNVHYXRT-BQWXUCBYSA-N 0.000 description 1
- 108010011619 6-Phytase Proteins 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 101150054149 ANGPTL4 gene Proteins 0.000 description 1
- 108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 description 1
- 108010072151 Agouti Signaling Protein Proteins 0.000 description 1
- 102000006822 Agouti Signaling Protein Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 108700042530 Angiopoietin-Like Protein 4 Proteins 0.000 description 1
- 102100025668 Angiopoietin-related protein 3 Human genes 0.000 description 1
- 102000009840 Angiopoietins Human genes 0.000 description 1
- 108010009906 Angiopoietins Proteins 0.000 description 1
- 102400000068 Angiostatin Human genes 0.000 description 1
- 108010079709 Angiostatins Proteins 0.000 description 1
- 102000008873 Angiotensin II receptor Human genes 0.000 description 1
- 108050000824 Angiotensin II receptor Proteins 0.000 description 1
- 102000005666 Apolipoprotein A-I Human genes 0.000 description 1
- 108010059886 Apolipoprotein A-I Proteins 0.000 description 1
- 102100029470 Apolipoprotein E Human genes 0.000 description 1
- 108010071619 Apolipoproteins Proteins 0.000 description 1
- 102000007592 Apolipoproteins Human genes 0.000 description 1
- 102000018616 Apolipoproteins B Human genes 0.000 description 1
- 108010027006 Apolipoproteins B Proteins 0.000 description 1
- 102000013933 Apolipoproteins D Human genes 0.000 description 1
- 108010025614 Apolipoproteins D Proteins 0.000 description 1
- 108010025628 Apolipoproteins E Proteins 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000031729 Bacteremia Diseases 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 108010075254 C-Peptide Proteins 0.000 description 1
- 229940124638 COX inhibitor Drugs 0.000 description 1
- 101150071146 COX2 gene Proteins 0.000 description 1
- 101000715943 Caenorhabditis elegans Cyclin-dependent kinase 4 homolog Proteins 0.000 description 1
- 101100114534 Caenorhabditis elegans ctc-2 gene Proteins 0.000 description 1
- 101100314454 Caenorhabditis elegans tra-1 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 description 1
- 108700005376 Cartilage Oligomeric Matrix Proteins 0.000 description 1
- 102000055007 Cartilage Oligomeric Matrix Human genes 0.000 description 1
- 102000004171 Cathepsin K Human genes 0.000 description 1
- 108090000625 Cathepsin K Proteins 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 108010075016 Ceruloplasmin Proteins 0.000 description 1
- 102100023321 Ceruloplasmin Human genes 0.000 description 1
- 241000040710 Chela Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 108010038447 Chromogranin A Proteins 0.000 description 1
- 102000010792 Chromogranin A Human genes 0.000 description 1
- 241000588923 Citrobacter Species 0.000 description 1
- 241000588919 Citrobacter freundii Species 0.000 description 1
- 102100029117 Coagulation factor X Human genes 0.000 description 1
- 102100030556 Coagulation factor XII Human genes 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000270722 Crocodylidae Species 0.000 description 1
- 241000484025 Cuniculus Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 101100481408 Danio rerio tie2 gene Proteins 0.000 description 1
- ZAHDXEIQWWLQQL-IHRRRGAJSA-N Deoxypyridinoline Chemical compound OC(=O)[C@@H](N)CCCC[N+]1=CC(O)=C(C[C@H](N)C([O-])=O)C(CC[C@H](N)C(O)=O)=C1 ZAHDXEIQWWLQQL-IHRRRGAJSA-N 0.000 description 1
- 101100198428 Dictyostelium discoideum ddiA gene Proteins 0.000 description 1
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
- BVTJGGGYKAMDBN-UHFFFAOYSA-N Dioxetane Chemical compound C1COO1 BVTJGGGYKAMDBN-UHFFFAOYSA-N 0.000 description 1
- 102000015554 Dopamine receptor Human genes 0.000 description 1
- 108050004812 Dopamine receptor Proteins 0.000 description 1
- 206010013710 Drug interaction Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000001301 EGF receptor Human genes 0.000 description 1
- 108060006698 EGF receptor Proteins 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 241000508725 Elymus repens Species 0.000 description 1
- 102400001047 Endostatin Human genes 0.000 description 1
- 108010079505 Endostatins Proteins 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000194031 Enterococcus faecium Species 0.000 description 1
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 description 1
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 108091008794 FGF receptors Proteins 0.000 description 1
- 108010080865 Factor XII Proteins 0.000 description 1
- 108010071289 Factor XIII Proteins 0.000 description 1
- 102100030421 Fatty acid-binding protein 5 Human genes 0.000 description 1
- 101710118908 Fatty acid-binding protein, adipocyte Proteins 0.000 description 1
- 102100032596 Fibrocystin Human genes 0.000 description 1
- 101710182545 Fibrocystin Proteins 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- 229910005540 GaP Inorganic materials 0.000 description 1
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 1
- 108010004460 Gastric Inhibitory Polypeptide Proteins 0.000 description 1
- 102100039994 Gastric inhibitory polypeptide Human genes 0.000 description 1
- 101800001586 Ghrelin Proteins 0.000 description 1
- 102400000442 Ghrelin-28 Human genes 0.000 description 1
- 102100039289 Glial fibrillary acidic protein Human genes 0.000 description 1
- 101710193519 Glial fibrillary acidic protein Proteins 0.000 description 1
- 102400000320 Glicentin Human genes 0.000 description 1
- 101800002945 Glicentin Proteins 0.000 description 1
- 102400000321 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 108010088406 Glucagon-Like Peptides Proteins 0.000 description 1
- 102400000322 Glucagon-like peptide 1 Human genes 0.000 description 1
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 1
- 101800000224 Glucagon-like peptide 1 Proteins 0.000 description 1
- 102400000326 Glucagon-like peptide 2 Human genes 0.000 description 1
- 101800000221 Glucagon-like peptide 2 Proteins 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010086677 Gonadotropins Proteins 0.000 description 1
- 102000006771 Gonadotropins Human genes 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 108010009202 Growth Factor Receptors Proteins 0.000 description 1
- 102000009465 Growth Factor Receptors Human genes 0.000 description 1
- 102100039939 Growth/differentiation factor 8 Human genes 0.000 description 1
- 241000606822 Haemophilus parahaemolyticus Species 0.000 description 1
- 241000606766 Haemophilus parainfluenzae Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000001688 Herpes Genitalis Diseases 0.000 description 1
- 102000002268 Hexosaminidases Human genes 0.000 description 1
- 108010000540 Hexosaminidases Proteins 0.000 description 1
- 102000000543 Histamine Receptors Human genes 0.000 description 1
- 108010002059 Histamine Receptors Proteins 0.000 description 1
- 241001272567 Hominoidea Species 0.000 description 1
- 101000693085 Homo sapiens Angiopoietin-related protein 3 Proteins 0.000 description 1
- 101000693076 Homo sapiens Angiopoietin-related protein 4 Proteins 0.000 description 1
- 101001062855 Homo sapiens Fatty acid-binding protein 5 Proteins 0.000 description 1
- 101001062864 Homo sapiens Fatty acid-binding protein, adipocyte Proteins 0.000 description 1
- 101000623901 Homo sapiens Mucin-16 Proteins 0.000 description 1
- 101001024605 Homo sapiens Next to BRCA1 gene 1 protein Proteins 0.000 description 1
- 101000692455 Homo sapiens Platelet-derived growth factor receptor beta Proteins 0.000 description 1
- 101000821885 Homo sapiens Protein S100-B Proteins 0.000 description 1
- 101000597785 Homo sapiens Tumor necrosis factor receptor superfamily member 6B Proteins 0.000 description 1
- 101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 102100024319 Intestinal-type alkaline phosphatase Human genes 0.000 description 1
- 101710184243 Intestinal-type alkaline phosphatase Proteins 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical group [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 102100035792 Kininogen-1 Human genes 0.000 description 1
- 108010077861 Kininogens Proteins 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 102000008238 LHRH Receptors Human genes 0.000 description 1
- 108010021290 LHRH Receptors Proteins 0.000 description 1
- 102000019298 Lipocalin Human genes 0.000 description 1
- 108050006654 Lipocalin Proteins 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- 102000003792 Metallothionein Human genes 0.000 description 1
- 108090000157 Metallothionein Proteins 0.000 description 1
- 102400001357 Motilin Human genes 0.000 description 1
- 101800002372 Motilin Proteins 0.000 description 1
- 102100023123 Mucin-16 Human genes 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 101100335081 Mus musculus Flt3 gene Proteins 0.000 description 1
- 101100481410 Mus musculus Tek gene Proteins 0.000 description 1
- 208000029578 Muscle disease Diseases 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 108010056852 Myostatin Proteins 0.000 description 1
- 101150111783 NTRK1 gene Proteins 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 102000004067 Osteocalcin Human genes 0.000 description 1
- 108090000573 Osteocalcin Proteins 0.000 description 1
- 102100040556 Osteocrin Human genes 0.000 description 1
- 101710089325 Osteocrin Proteins 0.000 description 1
- 101150000187 PTGS2 gene Proteins 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 108010067035 Pancrelipase Proteins 0.000 description 1
- 102100029909 Peptide YY Human genes 0.000 description 1
- 108010088847 Peptide YY Proteins 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 108090000113 Plasma Kallikrein Proteins 0.000 description 1
- 102000013566 Plasminogen Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 102000004211 Platelet factor 4 Human genes 0.000 description 1
- 108090000778 Platelet factor 4 Proteins 0.000 description 1
- 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 description 1
- 102100036142 Polycystin-2 Human genes 0.000 description 1
- 101710146368 Polycystin-2 Proteins 0.000 description 1
- 102000007584 Prealbumin Human genes 0.000 description 1
- 108010071690 Prealbumin Proteins 0.000 description 1
- 108010048233 Procalcitonin Proteins 0.000 description 1
- 102000015433 Prostaglandin Receptors Human genes 0.000 description 1
- 108010050183 Prostaglandin Receptors Proteins 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 108090000315 Protein Kinase C Proteins 0.000 description 1
- 229940096437 Protein S Drugs 0.000 description 1
- 108010066124 Protein S Proteins 0.000 description 1
- 102000029301 Protein S Human genes 0.000 description 1
- 102100021487 Protein S100-B Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- 102000007466 Purinergic P2 Receptors Human genes 0.000 description 1
- 108010085249 Purinergic P2 Receptors Proteins 0.000 description 1
- LCYXYLLJXMAEMT-SAXRGWBVSA-N Pyridinoline Chemical compound OC(=O)[C@@H](N)CCC1=C[N+](C[C@H](O)CC[C@H](N)C([O-])=O)=CC(O)=C1C[C@H](N)C(O)=O LCYXYLLJXMAEMT-SAXRGWBVSA-N 0.000 description 1
- 102000014128 RANK Ligand Human genes 0.000 description 1
- 108010025832 RANK Ligand Proteins 0.000 description 1
- 238000012952 Resampling Methods 0.000 description 1
- 101710102802 Runt-related transcription factor 2 Proteins 0.000 description 1
- 101000744436 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Trans-acting factor D Proteins 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 229940121742 Serine/threonine kinase inhibitor Drugs 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 241000191978 Staphylococcus simulans Species 0.000 description 1
- 241000122973 Stenotrophomonas maltophilia Species 0.000 description 1
- 241000529895 Stercorarius Species 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 1
- 102000013530 TOR Serine-Threonine Kinases Human genes 0.000 description 1
- 102000007591 Tartrate-Resistant Acid Phosphatase Human genes 0.000 description 1
- 108010032050 Tartrate-Resistant Acid Phosphatase Proteins 0.000 description 1
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 108010033576 Transferrin Receptors Proteins 0.000 description 1
- 102100026144 Transferrin receptor protein 1 Human genes 0.000 description 1
- 241000589884 Treponema pallidum Species 0.000 description 1
- 208000005448 Trichomonas Infections Diseases 0.000 description 1
- 241000224527 Trichomonas vaginalis Species 0.000 description 1
- 206010044620 Trichomoniasis Diseases 0.000 description 1
- 102000013394 Troponin I Human genes 0.000 description 1
- 102100033469 Tubulointerstitial nephritis antigen-like Human genes 0.000 description 1
- 102100035284 Tumor necrosis factor receptor superfamily member 6B Human genes 0.000 description 1
- 208000035896 Twin-reversed arterial perfusion sequence Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241000202921 Ureaplasma urealyticum Species 0.000 description 1
- 102100040613 Uromodulin Human genes 0.000 description 1
- 108010027007 Uromodulin Proteins 0.000 description 1
- 102000003848 Uteroglobin Human genes 0.000 description 1
- 108090000203 Uteroglobin Proteins 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 206010058874 Viraemia Diseases 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000001736 anti-fibrinolysin Effects 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 230000003460 anti-nuclear Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 244000078885 bloodborne pathogen Species 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 210000000233 bronchiolar non-ciliated Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 201000004308 chancroid Diseases 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000012767 chemiluminescent enzyme immunoassay Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical class C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 210000003555 cloaca Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000000205 computational method Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 229940111134 coxibs Drugs 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 125000001295 dansyl group Chemical group [H]C1=C([H])C(N(C([H])([H])[H])C([H])([H])[H])=C2C([H])=C([H])C([H])=C(C2=C1[H])S(*)(=O)=O 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- LNNWVNGFPYWNQE-GMIGKAJZSA-N desomorphine Chemical compound C1C2=CC=C(O)C3=C2[C@]24CCN(C)[C@H]1[C@@H]2CCC[C@@H]4O3 LNNWVNGFPYWNQE-GMIGKAJZSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000021004 dietary regimen Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
- 239000013024 dilution buffer Substances 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
- NJDNXYGOVLYJHP-UHFFFAOYSA-L disodium;2-(3-oxido-6-oxoxanthen-9-yl)benzoate Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=CC(=O)C=C2OC2=CC([O-])=CC=C21 NJDNXYGOVLYJHP-UHFFFAOYSA-L 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000009513 drug distribution Methods 0.000 description 1
- 230000008406 drug-drug interaction Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 238000005370 electroosmosis Methods 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 229960004222 factor ix Drugs 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000011152 fibreglass Substances 0.000 description 1
- 102000052178 fibroblast growth factor receptor activity proteins Human genes 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007701 flash-distillation Methods 0.000 description 1
- 244000144992 flock Species 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
- 201000004946 genital herpes Diseases 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNKDKYIHGQKHHM-RJKLHVOGSA-N ghrelin Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)COC(=O)CCCCCCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CC=CC=C1 GNKDKYIHGQKHHM-RJKLHVOGSA-N 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 210000005046 glial fibrillary acidic protein Anatomy 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- TWSALRJGPBVBQU-PKQQPRCHSA-N glucagon-like peptide 2 Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O)[C@@H](C)CC)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)CC)C1=CC=CC=C1 TWSALRJGPBVBQU-PKQQPRCHSA-N 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 108091005995 glycated hemoglobin Proteins 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 239000002622 gonadotropin Substances 0.000 description 1
- 229940094892 gonadotropins Drugs 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 108010011705 herstatin Proteins 0.000 description 1
- 150000007857 hydrazones Chemical class 0.000 description 1
- 150000004680 hydrogen peroxides Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 238000013198 immunometric assay Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000000893 inhibin Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- CWWARWOPSKGELM-SARDKLJWSA-N methyl (2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-5-amino-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-1-[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-5 Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)OC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 CWWARWOPSKGELM-SARDKLJWSA-N 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 238000001393 microlithography Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 230000000683 nonmetastatic effect Effects 0.000 description 1
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 125000003452 oxalyl group Chemical group *C(=O)C(*)=O 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000005622 photoelectricity Effects 0.000 description 1
- 229920002120 photoresistant polymer Polymers 0.000 description 1
- YSZIOXAEADAJLX-UHFFFAOYSA-N phthalazine-1,4-dione Chemical class C1=CC=C2C(=O)N=NC(=O)C2=C1 YSZIOXAEADAJLX-UHFFFAOYSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229940085127 phytase Drugs 0.000 description 1
- 238000001020 plasma etching Methods 0.000 description 1
- 230000010118 platelet activation Effects 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- CWCXERYKLSEGEZ-KDKHKZEGSA-N procalcitonin Chemical compound C([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(O)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](N)CSSC1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 CWCXERYKLSEGEZ-KDKHKZEGSA-N 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 239000012474 protein marker Substances 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000005258 radioactive decay Effects 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000036391 respiratory frequency Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- WHALSQRTWNBBCV-UHFFFAOYSA-N s-aminosulfanylthiohydroxylamine Chemical compound NSSN WHALSQRTWNBBCV-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 150000003376 silicon Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 229940037648 staphylococcus simulans Drugs 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical compound FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 238000000427 thin-film deposition Methods 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 229960000187 tissue plasminogen activator Drugs 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical class OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 description 1
- 239000005483 tyrosine kinase inhibitor Substances 0.000 description 1
- 150000004917 tyrosine kinase inhibitor derivatives Chemical class 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 238000007704 wet chemistry method Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/76—Chemiluminescence; Bioluminescence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/14—Devices for taking samples of blood ; Measuring characteristics of blood in vivo, e.g. gas concentration within the blood, pH-value of blood
- A61B5/1405—Devices for taking blood samples
- A61B5/1411—Devices for taking blood samples by percutaneous method, e.g. by lancet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/14—Devices for taking samples of blood ; Measuring characteristics of blood in vivo, e.g. gas concentration within the blood, pH-value of blood
- A61B5/1405—Devices for taking blood samples
- A61B5/1427—Multiple blood sampling, e.g. at periodic or pre-established intervals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15142—Devices intended for single use, i.e. disposable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/157—Devices characterised by integrated means for measuring characteristics of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/412—Detecting or monitoring sepsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/417—Evaluating particular organs or parts of the immune or lymphatic systems the bone marrow
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/50273—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the means or forces applied to move the fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5302—Apparatus specially adapted for immunological test procedures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1495—Calibrating or testing of in-vivo probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150015—Source of blood
- A61B5/150022—Source of blood for capillary blood or interstitial fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150053—Details for enhanced collection of blood or interstitial fluid at the sample site, e.g. by applying compression, heat, vibration, ultrasound, suction or vacuum to tissue; for reduction of pain or discomfort; Skin piercing elements, e.g. blades, needles, lancets or canulas, with adjustable piercing speed
- A61B5/150061—Means for enhancing collection
- A61B5/150099—Means for enhancing collection by negative pressure, other than vacuum extraction into a syringe by pulling on the piston rod or into pre-evacuated tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
- A61B5/150251—Collection chamber divided into at least two compartments, e.g. for division of samples
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150763—Details with identification means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150847—Communication to or from blood sampling device
- A61B5/150854—Communication to or from blood sampling device long distance, e.g. between patient's home and doctor's office
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/02—Identification, exchange or storage of information
- B01L2300/021—Identification, e.g. bar codes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/02—Identification, exchange or storage of information
- B01L2300/023—Sending and receiving of information, e.g. using bluetooth
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/04—Closures and closing means
- B01L2300/041—Connecting closures to device or container
- B01L2300/044—Connecting closures to device or container pierceable, e.g. films, membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0627—Sensor or part of a sensor is integrated
- B01L2300/0636—Integrated biosensor, microarrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0816—Cards, e.g. flat sample carriers usually with flow in two horizontal directions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0867—Multiple inlets and one sample wells, e.g. mixing, dilution
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/087—Multiple sequential chambers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0877—Flow chambers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0883—Serpentine channels
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0887—Laminated structure
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/11—Automated chemical analysis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/11—Automated chemical analysis
- Y10T436/115831—Condition or time responsive
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/12—Condition responsive control
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Optics & Photonics (AREA)
- Vascular Medicine (AREA)
- Clinical Laboratory Science (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- General Business, Economics & Management (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Business, Economics & Management (AREA)
- Plasma & Fusion (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
Abstract
Description
A | 3.37E+04 |
B | 1.01E+00 |
C | 2.10E+02 |
D | 3.56E+03 |
A | 1.20E+02 |
B | 1.996189 |
C | 292.7824 |
D | -0.14393 |
E | -287.931 |
C | x1 | S(x1) | x2 | S(x1+x2) | x2回收 | x1回收 |
pg/ml | pg/ml | % | % | |||
500 | 100 | 2.88E+04 | 500 | 1.73E+06 | 42 | 100 |
210 | 100 | 2.40E+04 | 500 | 1.13E+04 | 100 | 100 |
50 | 100 | 1.36E+04 | 500 | 5.83E+03 | 420 | 100 |
500 | 316 | 2.21E+04 | 500 | 1.50E+04 | 42 | 100 |
210 | 316 | 1.56E+04 | 500 | 9.66E+03 | 100 | 100 |
50 | 316 | 7.61E+03 | 500 | 5.25E+03 | 420 | 100 |
500 | 100 | 2.88E+04 | 200 | 2.25E+04 | 42 | 100 |
210 | 100 | 2.40E+04 | 200 | 1.60E+04 | 100 | 100 |
50 | 100 | 1.36E+04 | 200 | 7.80E+03 | 420 | 100 |
500 | 316 | 2.21E+04 | 200 | 1.84E+04 | 42 | 100 |
210 | 316 | 1.56E+04 | 200 | 1.22E+04 | 100 | 100 |
50 | 316 | 7.61E+03 | 200 | 6.16E+03 | 420 | 100 |
Claims (81)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67880105P | 2005-05-09 | 2005-05-09 | |
US60/678,801 | 2005-05-09 | ||
US70548905P | 2005-08-05 | 2005-08-05 | |
US60/705,489 | 2005-08-05 | ||
US71719205P | 2005-09-16 | 2005-09-16 | |
US60/717,192 | 2005-09-16 | ||
US72109705P | 2005-09-28 | 2005-09-28 | |
US60/721,097 | 2005-09-28 | ||
PCT/US2006/011090 WO2006121510A2 (en) | 2005-05-09 | 2006-03-24 | Point-of-care fluidic systems and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101535499A CN101535499A (zh) | 2009-09-16 |
CN101535499B true CN101535499B (zh) | 2017-04-19 |
Family
ID=37397025
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200680024658.XA Active CN101535499B (zh) | 2005-05-09 | 2006-03-24 | 点护理流体系统及其应用 |
Country Status (13)
Country | Link |
---|---|
US (20) | US7888125B2 (zh) |
EP (2) | EP3763824A1 (zh) |
JP (10) | JP2008544214A (zh) |
KR (8) | KR101931899B1 (zh) |
CN (1) | CN101535499B (zh) |
AU (1) | AU2006244617B2 (zh) |
CA (2) | CA3209322A1 (zh) |
DE (1) | DE20190164T1 (zh) |
ES (1) | ES2820430T3 (zh) |
IL (3) | IL187272A (zh) |
MX (3) | MX340077B (zh) |
NZ (6) | NZ603613A (zh) |
WO (1) | WO2006121510A2 (zh) |
Families Citing this family (341)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190357827A1 (en) | 2003-08-01 | 2019-11-28 | Dexcom, Inc. | Analyte sensor |
GB0402131D0 (en) | 2004-01-30 | 2004-03-03 | Isis Innovation | Delivery method |
US7697967B2 (en) | 2005-12-28 | 2010-04-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US7888125B2 (en) | 2005-05-09 | 2011-02-15 | Theranos, Inc. | Calibration of fluidic devices |
CA2607661C (en) | 2005-05-09 | 2017-08-08 | Idaho Technology, Inc. | A device and method for two-stage nucleic acid amplification |
EP1921980A4 (en) | 2005-08-31 | 2010-03-10 | Univ Virginia | IMPROVING THE PRECISION OF CONTINUOUS GLUCOSE SENSORS |
US20070112796A1 (en) * | 2005-11-17 | 2007-05-17 | Jung Edward K | Research in providing assistance related to health |
US10042980B2 (en) * | 2005-11-17 | 2018-08-07 | Gearbox Llc | Providing assistance related to health |
US20070112589A1 (en) * | 2005-11-17 | 2007-05-17 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | User interface for providing assistance related to health |
US20070119928A1 (en) * | 2005-11-17 | 2007-05-31 | Jung Edward K | Generating a nutraceutical request from an inventory |
US20070112592A1 (en) | 2005-11-17 | 2007-05-17 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Payments in providing assistance related to health |
US8532938B2 (en) | 2005-11-17 | 2013-09-10 | The Invention Science Fund I, Llc | Testing-dependent administration of a nutraceutical |
US7974856B2 (en) | 2005-11-30 | 2011-07-05 | The Invention Science Fund I, Llc | Computational systems and methods related to nutraceuticals |
US20080241935A1 (en) * | 2007-03-27 | 2008-10-02 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods for pathogen detection |
US8000981B2 (en) | 2005-11-30 | 2011-08-16 | The Invention Science Fund I, Llc | Methods and systems related to receiving nutraceutical associated information |
US20080241909A1 (en) * | 2007-03-27 | 2008-10-02 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Microfluidic chips for pathogen detection |
US20080033763A1 (en) * | 2005-11-30 | 2008-02-07 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems related to receiving nutraceutical associated information |
US8297028B2 (en) | 2006-06-14 | 2012-10-30 | The Invention Science Fund I, Llc | Individualized pharmaceutical selection and packaging |
US20080082272A1 (en) * | 2005-11-30 | 2008-04-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational systems and methods related to nutraceuticals |
US20070124175A1 (en) * | 2005-11-30 | 2007-05-31 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware. | Computational and/or control systems and methods related to nutraceutical agent selection and dosing |
US8068991B2 (en) | 2005-11-30 | 2011-11-29 | The Invention Science Fund I, Llc | Systems and methods for transmitting pathogen related information and responding |
US7827042B2 (en) | 2005-11-30 | 2010-11-02 | The Invention Science Fund I, Inc | Methods and systems related to transmission of nutraceutical associated information |
US20080004909A1 (en) * | 2005-11-30 | 2008-01-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational systems related to nutraceuticals |
US20070299693A1 (en) * | 2006-06-23 | 2007-12-27 | Searete Llc, A Limited Liability Corporation | Customized visual marking for medication labeling |
US20080193919A1 (en) * | 2005-11-30 | 2008-08-14 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems and methods for receiving pathogen related information and responding |
US7927787B2 (en) | 2006-06-28 | 2011-04-19 | The Invention Science Fund I, Llc | Methods and systems for analysis of nutraceutical associated components |
US20080178692A1 (en) * | 2007-01-29 | 2008-07-31 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Fluidic methods |
US20080241000A1 (en) * | 2007-03-27 | 2008-10-02 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems for pathogen detection |
US20080179255A1 (en) * | 2007-01-29 | 2008-07-31 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Fluidic devices |
US20070124218A1 (en) * | 2005-11-30 | 2007-05-31 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational and/or control systems related to individualized nutraceutical selection and packaging |
US8340944B2 (en) | 2005-11-30 | 2012-12-25 | The Invention Science Fund I, Llc | Computational and/or control systems and methods related to nutraceutical agent selection and dosing |
US10296720B2 (en) | 2005-11-30 | 2019-05-21 | Gearbox Llc | Computational systems and methods related to nutraceuticals |
US11298058B2 (en) | 2005-12-28 | 2022-04-12 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US7736310B2 (en) | 2006-01-30 | 2010-06-15 | Abbott Diabetes Care Inc. | On-body medical device securement |
US7885698B2 (en) | 2006-02-28 | 2011-02-08 | Abbott Diabetes Care Inc. | Method and system for providing continuous calibration of implantable analyte sensors |
WO2007106579A2 (en) * | 2006-03-15 | 2007-09-20 | Micronics, Inc. | Integrated nucleic acid assays |
US8741230B2 (en) | 2006-03-24 | 2014-06-03 | Theranos, Inc. | Systems and methods of sample processing and fluid control in a fluidic system |
US11287421B2 (en) | 2006-03-24 | 2022-03-29 | Labrador Diagnostics Llc | Systems and methods of sample processing and fluid control in a fluidic system |
US8473022B2 (en) | 2008-01-31 | 2013-06-25 | Abbott Diabetes Care Inc. | Analyte sensor with time lag compensation |
US9675290B2 (en) | 2012-10-30 | 2017-06-13 | Abbott Diabetes Care Inc. | Sensitivity calibration of in vivo sensors used to measure analyte concentration |
US9392969B2 (en) | 2008-08-31 | 2016-07-19 | Abbott Diabetes Care Inc. | Closed loop control and signal attenuation detection |
US7630748B2 (en) | 2006-10-25 | 2009-12-08 | Abbott Diabetes Care Inc. | Method and system for providing analyte monitoring |
US7618369B2 (en) | 2006-10-02 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for dynamically updating calibration parameters for an analyte sensor |
US8219173B2 (en) | 2008-09-30 | 2012-07-10 | Abbott Diabetes Care Inc. | Optimizing analyte sensor calibration |
US7653425B2 (en) | 2006-08-09 | 2010-01-26 | Abbott Diabetes Care Inc. | Method and system for providing calibration of an analyte sensor in an analyte monitoring system |
US8346335B2 (en) | 2008-03-28 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US8374668B1 (en) | 2007-10-23 | 2013-02-12 | Abbott Diabetes Care Inc. | Analyte sensor with lag compensation |
US8224415B2 (en) | 2009-01-29 | 2012-07-17 | Abbott Diabetes Care Inc. | Method and device for providing offset model based calibration for analyte sensor |
US8140312B2 (en) | 2007-05-14 | 2012-03-20 | Abbott Diabetes Care Inc. | Method and system for determining analyte levels |
US8478557B2 (en) | 2009-07-31 | 2013-07-02 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte monitoring system calibration accuracy |
US8007999B2 (en) | 2006-05-10 | 2011-08-30 | Theranos, Inc. | Real-time detection of influenza virus |
US8137626B2 (en) | 2006-05-19 | 2012-03-20 | California Institute Of Technology | Fluorescence detector, filter device and related methods |
EP2302395B1 (en) * | 2006-06-07 | 2015-04-15 | Health Diagnostic Laboratory, Inc. | Markers associated with arteriovascular events and methods of use thereof |
US20080177149A1 (en) * | 2006-06-16 | 2008-07-24 | Stefan Weinert | System and method for collecting patient information from which diabetes therapy may be determined |
US20080086338A1 (en) * | 2006-06-23 | 2008-04-10 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Customized visual marking for medication labeling |
US20070299695A1 (en) * | 2006-06-23 | 2007-12-27 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Customized visual marking for medication labeling |
US8252160B2 (en) * | 2006-07-28 | 2012-08-28 | Hewlett-Packard Development Company, L.P. | Prevention of fluid delivered to reservoir from wicking into channels within microfluidic device |
US7846110B2 (en) * | 2006-08-03 | 2010-12-07 | Advanced Medical Products Gmbh | Self-contained test unit for testing body fluids |
US20080154530A1 (en) * | 2006-09-01 | 2008-06-26 | Murray David W | Method for normalized test line limits with measurement uncertainty |
WO2008036614A1 (en) * | 2006-09-18 | 2008-03-27 | California Institute Of Technology | Apparatus for detecting target molecules and related methods |
US20080085507A1 (en) * | 2006-10-05 | 2008-04-10 | Affinex, Llc | System for rapid analysis of glycated proteinaceous species in biological samples |
US8012744B2 (en) | 2006-10-13 | 2011-09-06 | Theranos, Inc. | Reducing optical interference in a fluidic device |
SE530596C2 (sv) | 2006-10-13 | 2008-07-15 | Mathias Karlsson | Metod att fastställa syrebrist i blod från skalpen under förlossning |
US8008034B2 (en) * | 2006-10-13 | 2011-08-30 | Theranos, Inc. | Reducing optical interference in a fluidic device |
AU2013267006B2 (en) * | 2006-10-13 | 2015-06-11 | Labrador Diagnostics Llc | Reducing optical interference in a fluidic device |
CA2667119C (en) * | 2006-10-18 | 2016-04-12 | Axela Inc. | Measuring multiple analytes over a broad range of concentrations using optical diffraction |
WO2008052199A2 (en) | 2006-10-26 | 2008-05-02 | Abbott Diabetes Care, Inc. | Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors |
US20080113391A1 (en) | 2006-11-14 | 2008-05-15 | Ian Gibbons | Detection and quantification of analytes in bodily fluids |
US9102911B2 (en) | 2009-05-15 | 2015-08-11 | Biofire Diagnostics, Llc | High density self-contained biological analysis |
CA2671565A1 (en) * | 2006-12-01 | 2008-06-12 | Ameritox, Ltd. | Method and apparatus for generating toxicology reports |
US20090110933A1 (en) * | 2007-10-30 | 2009-04-30 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems and devices related to nitric oxide releasing materials |
US8642093B2 (en) * | 2007-10-30 | 2014-02-04 | The Invention Science Fund I, Llc | Methods and systems for use of photolyzable nitric oxide donors |
US20110190604A1 (en) * | 2006-12-22 | 2011-08-04 | Hyde Roderick A | Nitric oxide sensors and systems |
US20090112197A1 (en) * | 2007-10-30 | 2009-04-30 | Searete Llc | Devices configured to facilitate release of nitric oxide |
US20100285490A1 (en) * | 2006-12-29 | 2010-11-11 | Invitrogen Corporation | Detection apparatus |
US20080245740A1 (en) * | 2007-01-29 | 2008-10-09 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Fluidic methods |
US20090050569A1 (en) * | 2007-01-29 | 2009-02-26 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Fluidic methods |
US20090227005A1 (en) * | 2007-03-27 | 2009-09-10 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods for pathogen detection |
WO2008130896A1 (en) | 2007-04-14 | 2008-10-30 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in medical communication system |
WO2008130897A2 (en) | 2007-04-14 | 2008-10-30 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in medical communication system |
WO2009096992A1 (en) | 2007-04-14 | 2009-08-06 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in medical communication system |
WO2008130898A1 (en) | 2007-04-14 | 2008-10-30 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in medical communication system |
US9125548B2 (en) | 2007-05-14 | 2015-09-08 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8103471B2 (en) | 2007-05-14 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8600681B2 (en) | 2007-05-14 | 2013-12-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8239166B2 (en) | 2007-05-14 | 2012-08-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US10002233B2 (en) | 2007-05-14 | 2018-06-19 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8260558B2 (en) | 2007-05-14 | 2012-09-04 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8444560B2 (en) | 2007-05-14 | 2013-05-21 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8560038B2 (en) | 2007-05-14 | 2013-10-15 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
CA2691451C (en) | 2007-06-21 | 2015-03-24 | Sara H. Fan | Instrument and receptacles for performing processes |
US8160900B2 (en) | 2007-06-29 | 2012-04-17 | Abbott Diabetes Care Inc. | Analyte monitoring and management device and method to analyze the frequency of user interaction with the device |
US8834366B2 (en) | 2007-07-31 | 2014-09-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor calibration |
US8158430B1 (en) | 2007-08-06 | 2012-04-17 | Theranos, Inc. | Systems and methods of fluidic sample processing |
JP5044334B2 (ja) * | 2007-09-06 | 2012-10-10 | 株式会社ニコン | 採液収容装置 |
US11307201B2 (en) * | 2007-09-17 | 2022-04-19 | Red Ivory Llc | Self-actuating signal producing detection devices and methods |
SG10201606120XA (en) | 2007-10-02 | 2016-09-29 | Theranos Inc | Modular Point-Of-Care Devices And Uses Thereof |
JP5628677B2 (ja) | 2007-10-19 | 2014-11-19 | ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company | ベータ−ラクタマーゼの検出のための方法および組成物 |
US8377031B2 (en) | 2007-10-23 | 2013-02-19 | Abbott Diabetes Care Inc. | Closed loop control system with safety parameters and methods |
US8409093B2 (en) | 2007-10-23 | 2013-04-02 | Abbott Diabetes Care Inc. | Assessing measures of glycemic variability |
US8877508B2 (en) | 2007-10-30 | 2014-11-04 | The Invention Science Fund I, Llc | Devices and systems that deliver nitric oxide |
US10080823B2 (en) * | 2007-10-30 | 2018-09-25 | Gearbox Llc | Substrates for nitric oxide releasing devices |
US7846400B2 (en) * | 2007-10-30 | 2010-12-07 | The Invention Science Fund I, Llc | Substrates for nitric oxide releasing devices |
US20110182970A1 (en) * | 2007-10-30 | 2011-07-28 | Hyde Roderick A | Nitric oxide sensors and systems |
US8980332B2 (en) | 2007-10-30 | 2015-03-17 | The Invention Science Fund I, Llc | Methods and systems for use of photolyzable nitric oxide donors |
US20090112055A1 (en) * | 2007-10-30 | 2009-04-30 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Sleeves configured to facilitate release of nitric oxide |
CN103961792B (zh) * | 2007-12-17 | 2016-09-21 | 新世界药品有限公司 | 整合的真皮内递送、诊断和通讯系统 |
US20090164239A1 (en) | 2007-12-19 | 2009-06-25 | Abbott Diabetes Care, Inc. | Dynamic Display Of Glucose Information |
EP2231257A4 (en) | 2007-12-24 | 2013-11-06 | Univ Queensland | APPLICATION METHOD |
AU2013202929B2 (en) * | 2008-01-28 | 2016-05-26 | F. Hoffmann-La Roche Ag | System for detection of an analyte in a body fluid |
US7766846B2 (en) * | 2008-01-28 | 2010-08-03 | Roche Diagnostics Operations, Inc. | Rapid blood expression and sampling |
WO2009097660A1 (en) | 2008-02-07 | 2009-08-13 | The University Of Queensland | Patch production |
JP5628784B2 (ja) | 2008-03-17 | 2014-11-19 | コーニンクレッカ フィリップス エヌ ヴェ | 磁性粒子によるアッセイ用カートリッジ |
WO2009140735A1 (en) * | 2008-05-23 | 2009-11-26 | The University Of Queensland | Analyte detection by microneedle patch with analyte selective reagents. |
US8924159B2 (en) | 2008-05-30 | 2014-12-30 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US8591410B2 (en) | 2008-05-30 | 2013-11-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US8306594B2 (en) * | 2008-06-12 | 2012-11-06 | Paseman Sabrina K | Transmission fluorometer |
CN102105227B (zh) | 2008-06-19 | 2013-11-06 | 贝林格尔英格海姆米克罗帕茨有限责任公司 | 定量供应流体的容器 |
US20100017092A1 (en) * | 2008-07-16 | 2010-01-21 | Steven Wayne Butler | Hybrid fault isolation system utilizing both model-based and empirical components |
US9943644B2 (en) | 2008-08-31 | 2018-04-17 | Abbott Diabetes Care Inc. | Closed loop control with reference measurement and methods thereof |
US8734422B2 (en) | 2008-08-31 | 2014-05-27 | Abbott Diabetes Care Inc. | Closed loop control with improved alarm functions |
US20100057040A1 (en) | 2008-08-31 | 2010-03-04 | Abbott Diabetes Care, Inc. | Robust Closed Loop Control And Methods |
US8986208B2 (en) | 2008-09-30 | 2015-03-24 | Abbott Diabetes Care Inc. | Analyte sensor sensitivity attenuation mitigation |
GB2486842B (en) * | 2008-09-30 | 2013-06-12 | Menai Medical Technologies Ltd | Sample measurement system |
WO2010047778A1 (en) * | 2008-10-20 | 2010-04-29 | Becton Dickinson And Company | Compositions for the detection of intracellular bacterial targets and other intracellular microorganism targets |
US9326707B2 (en) | 2008-11-10 | 2016-05-03 | Abbott Diabetes Care Inc. | Alarm characterization for analyte monitoring devices and systems |
US8643837B2 (en) * | 2009-01-14 | 2014-02-04 | Alverix, Inc. | Methods and materials for calibration of a reader |
JP5086286B2 (ja) * | 2009-01-23 | 2012-11-28 | 株式会社日立ハイテクノロジーズ | 自動分析装置 |
US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
WO2010091246A2 (en) * | 2009-02-06 | 2010-08-12 | Northwestern University | Burstable liquid packaging and uses thereof |
US9295417B2 (en) | 2011-04-29 | 2016-03-29 | Seventh Sense Biosystems, Inc. | Systems and methods for collecting fluid from a subject |
EP2408372B1 (en) | 2009-03-02 | 2019-01-09 | Seventh Sense Biosystems, Inc. | Devices associated with blood sampling |
US9033898B2 (en) | 2010-06-23 | 2015-05-19 | Seventh Sense Biosystems, Inc. | Sampling devices and methods involving relatively little pain |
WO2012018486A2 (en) | 2010-07-26 | 2012-02-09 | Seventh Sense Biosystems, Inc. | Rapid delivery and/or receiving of fluids |
US20120277629A1 (en) | 2011-04-29 | 2012-11-01 | Seventh Sense Biosystems, Inc. | Systems and methods for collection and/or manipulation of blood spots or other bodily fluids |
US9041541B2 (en) | 2010-01-28 | 2015-05-26 | Seventh Sense Biosystems, Inc. | Monitoring or feedback systems and methods |
US8497777B2 (en) | 2009-04-15 | 2013-07-30 | Abbott Diabetes Care Inc. | Analyte monitoring system having an alert |
EP2425209A4 (en) | 2009-04-29 | 2013-01-09 | Abbott Diabetes Care Inc | METHOD AND SYSTEM FOR REAL-TIME CALIBRATION OF AN ANALYTICAL SENSOR WITH RETROACTIVE FILLING |
US8790916B2 (en) | 2009-05-14 | 2014-07-29 | Genestream, Inc. | Microfluidic method and system for isolating particles from biological fluid |
GB0911007D0 (en) | 2009-06-25 | 2009-08-12 | Univ Hospital Of North Staffordshire | Analyzer apparatus and methods for lung disease |
EP4309580A3 (en) | 2009-07-23 | 2024-02-28 | Abbott Diabetes Care Inc. | Continuous analyte measurement system |
EP3173014B1 (en) | 2009-07-23 | 2021-08-18 | Abbott Diabetes Care, Inc. | Real time management of data relating to physiological control of glucose levels |
EP4060331A1 (en) * | 2009-07-27 | 2022-09-21 | Meso Scale Technologies, LLC | Assay information management methods and devices |
WO2011026053A1 (en) | 2009-08-31 | 2011-03-03 | Abbott Diabetes Care Inc. | Displays for a medical device |
EP2482720A4 (en) | 2009-09-29 | 2014-04-23 | Abbott Diabetes Care Inc | METHOD AND APPARATUS FOR PROVIDING NOTIFICATION FUNCTION IN SUBSTANCE MONITORING SYSTEMS |
WO2011045937A1 (ja) * | 2009-10-14 | 2011-04-21 | 国立大学法人浜松医科大学 | 高機能自閉症の発症危険度を判定する方法およびマーカー |
CN105825049A (zh) | 2009-10-19 | 2016-08-03 | 提拉诺斯公司 | 集成的健康数据采集和分析系统 |
US8185181B2 (en) | 2009-10-30 | 2012-05-22 | Abbott Diabetes Care Inc. | Method and apparatus for detecting false hypoglycemic conditions |
CN102687018B (zh) * | 2009-11-16 | 2015-07-15 | 硅生物装置有限公司 | 化验用过滤装置 |
EP2504466B1 (en) | 2009-11-23 | 2019-11-20 | Proxim Diagnostics Corporation | Controlled electrochemical activation of carbon-based electrodes |
US10453157B2 (en) | 2010-01-22 | 2019-10-22 | Deka Products Limited Partnership | System, method, and apparatus for electronic patient care |
US10911515B2 (en) | 2012-05-24 | 2021-02-02 | Deka Products Limited Partnership | System, method, and apparatus for electronic patient care |
US10242159B2 (en) | 2010-01-22 | 2019-03-26 | Deka Products Limited Partnership | System and apparatus for electronic patient care |
US11244745B2 (en) | 2010-01-22 | 2022-02-08 | Deka Products Limited Partnership | Computer-implemented method, system, and apparatus for electronic patient care |
US20110313789A1 (en) | 2010-01-22 | 2011-12-22 | Deka Products Limited Partnership | Electronic patient monitoring system |
US11164672B2 (en) | 2010-01-22 | 2021-11-02 | Deka Products Limited Partnership | System and apparatus for electronic patient care |
US11881307B2 (en) | 2012-05-24 | 2024-01-23 | Deka Products Limited Partnership | System, method, and apparatus for electronic patient care |
US11210611B2 (en) | 2011-12-21 | 2021-12-28 | Deka Products Limited Partnership | System, method, and apparatus for electronic patient care |
KR101851117B1 (ko) | 2010-01-29 | 2018-04-23 | 마이크로닉스 인코포레이티드. | 샘플-투-앤서 마이크로유체 카트리지 |
US8790592B2 (en) | 2010-02-04 | 2014-07-29 | Bio-Rad Laboratories, Inc. | Measuring multi-analyte samples using an in-line flow cell |
EP2534494A4 (en) * | 2010-02-12 | 2016-05-04 | Univ Northwestern | ASSAY CARD FOR SAMPLING, PROCESSING AND REACTION |
WO2011112753A1 (en) | 2010-03-10 | 2011-09-15 | Abbott Diabetes Care Inc. | Systems, devices and methods for managing glucose levels |
JP6158078B2 (ja) * | 2010-04-19 | 2017-07-05 | バイオマーカー ストラテジーズ リミテッド ライアビリティ カンパニー | 薬物感受性、薬物抵抗性および疾患進行の予測のための組成物および方法 |
WO2011133794A1 (en) * | 2010-04-21 | 2011-10-27 | Regents Of The University Of Minnesota | A method for early prognosis of kidney disease |
US10092229B2 (en) | 2010-06-29 | 2018-10-09 | Abbott Diabetes Care Inc. | Calibration of analyte measurement system |
US9943673B2 (en) | 2010-07-14 | 2018-04-17 | Vaxxas Pty Limited | Patch applying apparatus |
US20120016308A1 (en) | 2010-07-16 | 2012-01-19 | Seventh Sense Biosystems, Inc. | Low-pressure packaging for fluid devices |
US20120039809A1 (en) | 2010-08-13 | 2012-02-16 | Seventh Sense Biosystems, Inc. | Systems and techniques for monitoring subjects |
EP2954916A3 (en) * | 2010-08-13 | 2016-04-20 | Seventh Sense Biosystems, Inc. | Clinical and/or consumer techniques and devices |
US20120208202A1 (en) * | 2010-09-17 | 2012-08-16 | Alere Scarborough, Inc. | Method for the Reduction of Biological Sampling Errors by Means of Image Processing |
WO2012064802A1 (en) | 2010-11-09 | 2012-05-18 | Seventh Sense Biosystems, Inc. | Systems and interfaces for blood sampling |
CN106248582B (zh) | 2011-01-21 | 2020-10-20 | 拉布拉多诊断有限责任公司 | 样品使用最大化的系统和方法 |
US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US8506803B2 (en) * | 2011-03-01 | 2013-08-13 | Wisconsin Alumni Research Foundation | Integrated electrospray ionization emitter and detection cell for parallel measurements by fluorescence and mass spectrometry |
US9580742B2 (en) | 2011-03-10 | 2017-02-28 | Shana O. Kelley | Diagnostic and sample preparation devices and methods |
US20120229808A1 (en) * | 2011-03-11 | 2012-09-13 | Electronics And Telecommunications Research Institute | Biochip identification apparatus, biochip and method of identifying biochip using the same |
ES2847578T3 (es) | 2011-04-15 | 2021-08-03 | Dexcom Inc | Calibración avanzada de sensor de analito y detección de errores |
EP2527814A1 (en) * | 2011-04-27 | 2012-11-28 | Koninklijke Philips Electronics N.V. | Sensor system with an exchangeable cartridge and a reader |
ES2597081T3 (es) | 2011-04-29 | 2017-01-13 | Seventh Sense Biosystems, Inc. | Entrega y/o recepción de fluidos |
US20130158468A1 (en) | 2011-12-19 | 2013-06-20 | Seventh Sense Biosystems, Inc. | Delivering and/or receiving material with respect to a subject surface |
WO2012166795A1 (en) * | 2011-05-30 | 2012-12-06 | String Therapeutics Inc. | Methods and compositions for therapeutic drug monitoring and dosing by point-of-care pharmacokinetic profiling |
US8655796B2 (en) | 2011-06-17 | 2014-02-18 | Sanjay Udani | Methods and systems for recording verifiable documentation |
US8606595B2 (en) | 2011-06-17 | 2013-12-10 | Sanjay Udani | Methods and systems for assuring compliance |
US8653715B1 (en) | 2011-06-30 | 2014-02-18 | The United States Of America As Represented By The Secretary Of The Navy | Radioisotope-powered energy source |
US9638663B2 (en) | 2011-07-25 | 2017-05-02 | Proxim Diagnostics Corporation | Cartridge for diagnostic testing |
US9268915B2 (en) | 2011-09-25 | 2016-02-23 | Theranos, Inc. | Systems and methods for diagnosis or treatment |
US8435738B2 (en) | 2011-09-25 | 2013-05-07 | Theranos, Inc. | Systems and methods for multi-analysis |
US8475739B2 (en) | 2011-09-25 | 2013-07-02 | Theranos, Inc. | Systems and methods for fluid handling |
US20140170735A1 (en) | 2011-09-25 | 2014-06-19 | Elizabeth A. Holmes | Systems and methods for multi-analysis |
US9664702B2 (en) | 2011-09-25 | 2017-05-30 | Theranos, Inc. | Fluid handling apparatus and configurations |
US9619627B2 (en) | 2011-09-25 | 2017-04-11 | Theranos, Inc. | Systems and methods for collecting and transmitting assay results |
US9632102B2 (en) | 2011-09-25 | 2017-04-25 | Theranos, Inc. | Systems and methods for multi-purpose analysis |
US8840838B2 (en) | 2011-09-25 | 2014-09-23 | Theranos, Inc. | Centrifuge configurations |
BR112014007073A2 (pt) * | 2011-09-25 | 2017-04-11 | Theranos Inc | sistemas e métodos para multi-análise |
US9250229B2 (en) | 2011-09-25 | 2016-02-02 | Theranos, Inc. | Systems and methods for multi-analysis |
US9810704B2 (en) | 2013-02-18 | 2017-11-07 | Theranos, Inc. | Systems and methods for multi-analysis |
US10012664B2 (en) | 2011-09-25 | 2018-07-03 | Theranos Ip Company, Llc | Systems and methods for fluid and component handling |
WO2013053022A1 (en) | 2011-10-12 | 2013-04-18 | The University Of Queensland | Delivery device |
WO2013066849A1 (en) | 2011-10-31 | 2013-05-10 | Abbott Diabetes Care Inc. | Model based variable risk false glucose threshold alarm prevention mechanism |
TWI457562B (zh) | 2011-11-22 | 2014-10-21 | Wistron Corp | 流式細胞儀及生物晶片檢測方法 |
US8710993B2 (en) | 2011-11-23 | 2014-04-29 | Abbott Diabetes Care Inc. | Mitigating single point failure of devices in an analyte monitoring system and methods thereof |
US9317656B2 (en) | 2011-11-23 | 2016-04-19 | Abbott Diabetes Care Inc. | Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof |
WO2013078426A2 (en) | 2011-11-25 | 2013-05-30 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods of use |
EP2786144A4 (en) | 2011-11-28 | 2015-07-29 | Immunoprofile Llc | INTERVENTION POINT IMMUNIZATION VERIFICATION SYSTEM |
US10449537B2 (en) * | 2011-12-15 | 2019-10-22 | Dna Medicine Institute, Inc. | Capillary manipulation of clinical samples |
US20150055132A1 (en) * | 2012-04-05 | 2015-02-26 | Renishaw Diagnostics Limited | Method for calibrating spectroscopy apparatus and equipment for use in the method |
US9081001B2 (en) | 2012-05-15 | 2015-07-14 | Wellstat Diagnostics, Llc | Diagnostic systems and instruments |
US9213043B2 (en) | 2012-05-15 | 2015-12-15 | Wellstat Diagnostics, Llc | Clinical diagnostic system including instrument and cartridge |
US9625465B2 (en) | 2012-05-15 | 2017-04-18 | Defined Diagnostics, Llc | Clinical diagnostic systems |
US9500639B2 (en) | 2012-07-18 | 2016-11-22 | Theranos, Inc. | Low-volume coagulation assay |
TW201831881A (zh) | 2012-07-25 | 2018-09-01 | 美商提拉諾斯股份有限公司 | 影像分析及生物樣本之量測 |
EP2890297B1 (en) | 2012-08-30 | 2018-04-11 | Abbott Diabetes Care, Inc. | Dropout detection in continuous analyte monitoring data during data excursions |
EP2891886B1 (en) * | 2012-08-31 | 2018-10-10 | The University of Tokyo | Detector and detection method |
GB2505706A (en) * | 2012-09-10 | 2014-03-12 | Univ Leiden | Apparatus comprising meniscus alignment barriers |
MX2015002919A (es) | 2012-09-11 | 2015-08-14 | Theranos Inc | Sistemas y metodos de manejo de informacion que utilizan una firma biologica. |
EP2901153A4 (en) | 2012-09-26 | 2016-04-27 | Abbott Diabetes Care Inc | METHOD AND DEVICE FOR IMPROVING DELAY CORRECTION FUNCTION DURING IN VIVO MEASUREMENT OF ANALYZ CONCENTRATION WITH ANALYZ CONCENTRATION VARIABILITY AND RANGE DATA |
US20140114676A1 (en) * | 2012-10-23 | 2014-04-24 | Theranos, Inc. | Drug Monitoring and Regulation Systems and Methods |
US20140322706A1 (en) * | 2012-10-24 | 2014-10-30 | Jon Faiz Kayyem | Integrated multipelx target analysis |
CA2889415C (en) | 2012-10-24 | 2020-06-02 | Genmark Diagnostics, Inc. | Integrated multiplex target analysis |
JP6328655B2 (ja) | 2012-11-15 | 2018-05-23 | オーソ・クリニカル・ダイアグノスティックス・インコーポレーテッド | 反応時間を使用してアッセイを較正すること |
WO2014083667A1 (ja) * | 2012-11-29 | 2014-06-05 | ミライアル株式会社 | サンドイッチ法による抗原抗体反応測定方法 |
EP2932268A4 (en) | 2012-12-17 | 2016-10-19 | Leukodx Ltd | SYSTEMS AND METHOD FOR RECOGNIZING A BIOLOGICAL CONDITION |
US10610861B2 (en) | 2012-12-17 | 2020-04-07 | Accellix Ltd. | Systems, compositions and methods for detecting a biological condition |
WO2014100725A1 (en) | 2012-12-21 | 2014-06-26 | Micronics, Inc. | Portable fluorescence detection system and microassay cartridge |
EP2935908B1 (en) | 2012-12-21 | 2019-08-14 | PerkinElmer Health Sciences, Inc. | Fluidic circuits and related manufacturing methods |
WO2014100743A2 (en) | 2012-12-21 | 2014-06-26 | Micronics, Inc. | Low elasticity films for microfluidic use |
US9805407B2 (en) | 2013-01-25 | 2017-10-31 | Illumina, Inc. | Methods and systems for using a cloud computing environment to configure and sell a biological sample preparation cartridge and share related data |
CA3209249A1 (en) | 2013-02-18 | 2014-08-21 | Theranos Ip Company, Llc | Image analysis and measurement of biological samples |
KR20150119365A (ko) | 2013-02-18 | 2015-10-23 | 테라노스, 인코포레이티드 | 다중 분석을 위한 시스템 및 방법 |
US11008628B1 (en) * | 2013-02-18 | 2021-05-18 | Labrador Diagnostics Llc | Systems and methods for analyte testing and laboratory oversight |
MX354033B (es) * | 2013-02-18 | 2018-02-09 | Theranos Ip Co Llc | Sistemas y métodos para recolectar y transmitir resultados de ensayos. |
US10401373B1 (en) | 2013-02-18 | 2019-09-03 | Theranos Ip Company, Llc | Systems and methods for analyte testing and laboratory oversight |
SG11201507011VA (en) | 2013-03-04 | 2015-10-29 | Theranos Inc | Network connectivity methods and systems |
CN104707674B (zh) | 2013-03-11 | 2018-06-15 | 克忧公司 | 用于检测和量化分析物的系统和方法 |
US9623409B2 (en) | 2013-03-11 | 2017-04-18 | Cue Inc. | Cartridges, kits, and methods for enhanced mixing for detection and quantification of analytes |
US10545161B2 (en) | 2013-03-11 | 2020-01-28 | Cue Health Inc. | Systems and methods for detection and quantification of analytes |
WO2014159354A1 (en) * | 2013-03-14 | 2014-10-02 | Bayer Healthcare Llc | Progressive approximation of sample analyte concentration |
CN110426436B (zh) * | 2013-03-14 | 2022-08-19 | 安晟信医疗科技控股公司 | 分析物浓度测定的系统误差补偿 |
WO2014152034A1 (en) | 2013-03-15 | 2014-09-25 | Abbott Diabetes Care Inc. | Sensor fault detection using analyte sensor data pattern comparison |
US9458488B2 (en) | 2013-03-15 | 2016-10-04 | Nanomix, Inc. | Point of care sensor systems |
US10433773B1 (en) | 2013-03-15 | 2019-10-08 | Abbott Diabetes Care Inc. | Noise rejection methods and apparatus for sparsely sampled analyte sensor data |
US9474475B1 (en) | 2013-03-15 | 2016-10-25 | Abbott Diabetes Care Inc. | Multi-rate analyte sensor data collection with sample rate configurable signal processing |
EP2969217A2 (en) | 2013-03-15 | 2016-01-20 | Genmark Diagnostics Inc. | Systems, methods, and apparatus for manipulating deformable fluid vessels |
WO2014182847A1 (en) | 2013-05-07 | 2014-11-13 | Micronics, Inc. | Device for preparation and analysis of nucleic acids |
CA2911303C (en) | 2013-05-07 | 2021-02-16 | Micronics, Inc. | Methods for preparation of nucleic acid-containing samples using clay minerals and alkaline solutions |
WO2014182844A1 (en) | 2013-05-07 | 2014-11-13 | Micronics, Inc. | Microfluidic devices and methods for performing serum separation and blood cross-matching |
JP6034238B2 (ja) * | 2013-05-17 | 2016-11-30 | 日本電信電話株式会社 | 血液凝固検査方法 |
EP3014262B1 (en) * | 2013-06-17 | 2023-08-09 | Waters Technologies Corporation | Compensation for chromatography column volume variations |
US20160153973A1 (en) * | 2013-07-09 | 2016-06-02 | Lucas David Smith | Device and method of rapid linker mediated label-based immunoassays |
US10422806B1 (en) | 2013-07-25 | 2019-09-24 | Theranos Ip Company, Llc | Methods for improving assays of biological samples |
WO2015019195A2 (en) * | 2013-08-07 | 2015-02-12 | Xagenic Inc. | Systems, devices, and methods for deploying onboard reagents in a diagnostic device |
US10082500B2 (en) * | 2013-08-22 | 2018-09-25 | Franz Baudenbacher | Device and method for detecting a target analyte |
WO2015035256A2 (en) | 2013-09-06 | 2015-03-12 | Theranos, Inc. | Devices, systems, methods and kits for receiving a swab |
CN111378568A (zh) | 2013-09-06 | 2020-07-07 | 赛拉诺斯知识产权有限责任公司 | 用于检测感染性疾病的系统和方法 |
US10943689B1 (en) | 2013-09-06 | 2021-03-09 | Labrador Diagnostics Llc | Systems and methods for laboratory testing and result management |
US11545241B1 (en) | 2013-09-07 | 2023-01-03 | Labrador Diagnostics Llc | Systems and methods for analyte testing and data management |
USD881409S1 (en) | 2013-10-24 | 2020-04-14 | Genmark Diagnostics, Inc. | Biochip cartridge |
US9498778B2 (en) | 2014-11-11 | 2016-11-22 | Genmark Diagnostics, Inc. | Instrument for processing cartridge for performing assays in a closed sample preparation and reaction system |
WO2015102745A1 (en) | 2013-12-31 | 2015-07-09 | Abbott Diabetes Care Inc. | Self-powered analyte sensor and devices using the same |
GB201401426D0 (en) * | 2014-01-28 | 2014-03-12 | Univ Strathclyde | Automated Assay |
US11360107B1 (en) | 2014-02-25 | 2022-06-14 | Labrador Diagnostics Llc | Systems and methods for sample handling |
CN106068230B (zh) * | 2014-03-12 | 2020-02-28 | 通用电气健康护理生物科学股份公司 | 用于化学合成的自动气体阀容器支座 |
US20170185748A1 (en) | 2014-03-30 | 2017-06-29 | Abbott Diabetes Care Inc. | Method and Apparatus for Determining Meal Start and Peak Events in Analyte Monitoring Systems |
GB2548944B (en) | 2014-04-17 | 2018-11-28 | Z Integrated Digital Tech Inc | Electronic test device data communication |
USD745423S1 (en) | 2014-05-12 | 2015-12-15 | Cue Inc. | Automated analyzer test cartridge and sample collection device for analyte detection |
US9987427B1 (en) * | 2014-06-24 | 2018-06-05 | National Technology & Engineering Solutions Of Sandia, Llc | Diagnostic/drug delivery “sense-respond” devices, systems, and uses thereof |
EP3161483A4 (en) * | 2014-06-25 | 2017-12-20 | ImmunoProfile, LLC | Point of care immunization testing system - detection methods |
WO2016007886A1 (en) | 2014-07-11 | 2016-01-14 | Northwestern University | Yeast-based biosensor |
EP3182874B1 (en) | 2014-08-22 | 2023-06-14 | Parmar, Jaywant P. | Advanced electromagnetic motion and tracking peripherally inserted central venous catheter system with extended endovascular applications |
EP2995937A1 (en) * | 2014-09-15 | 2016-03-16 | Sensirion AG | Integrated chemical sensor chip |
EP3198272B1 (en) | 2014-09-26 | 2022-04-06 | Abbott Point Of Care, Inc. | Cartridge device identification for coagulation assays in fluid samples |
CN106999932A (zh) | 2014-09-26 | 2017-08-01 | 雅培医护站股份有限公司 | 用于流体样本中的凝结测定的具有流体结的盒设备 |
US9921232B2 (en) | 2014-09-26 | 2018-03-20 | Abbott Point Of Care Inc. | Ellagic acid formulations for use in coagulation assays |
WO2016049545A1 (en) | 2014-09-26 | 2016-03-31 | Abbott Point Of Care Inc. | Single channel cartridge device for coagulation assays in fluid samples |
CN106999931B (zh) | 2014-09-26 | 2020-08-18 | 雅培医护站股份有限公司 | 具有用于测定流体样本中的凝结的微环境传感器的微制造设备 |
EP3198280B1 (en) | 2014-09-26 | 2021-05-26 | Abbott Point Of Care, Inc. | Sensors for assaying coagulation in fluid samples |
US10048281B2 (en) | 2014-09-26 | 2018-08-14 | Abbott Point Of Care Inc. | Cartridge device with segmented fluidics for assaying coagulation in fluid samples |
US10352899B2 (en) | 2014-10-06 | 2019-07-16 | ALVEO Technologies Inc. | System and method for detection of silver |
US10627358B2 (en) | 2014-10-06 | 2020-04-21 | Alveo Technologies, Inc. | Method for detection of analytes |
US9506908B2 (en) | 2014-10-06 | 2016-11-29 | Alveo Technologies, Inc. | System for detection of analytes |
US9921182B2 (en) | 2014-10-06 | 2018-03-20 | ALVEO Technologies Inc. | System and method for detection of mercury |
US10196678B2 (en) | 2014-10-06 | 2019-02-05 | ALVEO Technologies Inc. | System and method for detection of nucleic acids |
CN107003312B (zh) | 2014-10-08 | 2022-01-14 | 赛拉诺斯知识产权有限责任公司 | 用于埃博拉和其他传染病的实时诊断测试(rdt)的方法和装置 |
US10005080B2 (en) | 2014-11-11 | 2018-06-26 | Genmark Diagnostics, Inc. | Instrument and cartridge for performing assays in a closed sample preparation and reaction system employing electrowetting fluid manipulation |
WO2016087957A1 (en) * | 2014-12-05 | 2016-06-09 | Diasys Diagnostics India Private Limited | Multiplexed microfluidic device |
JP6613026B2 (ja) * | 2014-12-22 | 2019-11-27 | 日精株式会社 | 採血具 |
CA3012985A1 (en) | 2015-01-27 | 2016-08-04 | Kardiatonos, Inc. | Biomarkers of vascular disease |
CA2975275C (en) | 2015-02-02 | 2023-08-29 | Vaxxas Pty Limited | Microprojection array applicator and method |
WO2016134217A1 (en) * | 2015-02-19 | 2016-08-25 | Surface Sensing Technologies Llc | Device and method for detecting a target analyte |
EP3290928A4 (en) * | 2015-04-30 | 2018-10-10 | Sysmex Corporation | Liquid encapsulation cartridge, sample analysis device, and sample analysis method |
WO2017011346A1 (en) | 2015-07-10 | 2017-01-19 | Abbott Diabetes Care Inc. | System, device and method of dynamic glucose profile response to physiological parameters |
CN108136391B (zh) | 2015-07-17 | 2021-01-26 | 克忧健康公司 | 用于增强检测和分析物定量的系统及方法 |
JP6882782B2 (ja) | 2015-08-04 | 2021-06-02 | デューク ユニバーシティ | 遺伝子コードされた本質的に無秩序な送達用ステルスポリマーおよびその使用方法 |
WO2017045031A1 (en) | 2015-09-18 | 2017-03-23 | Vaxxas Pty Limited | Microprojection arrays with microprojections having large surface area profiles |
US11752213B2 (en) | 2015-12-21 | 2023-09-12 | Duke University | Surfaces having reduced non-specific binding and antigenicity |
US10088494B2 (en) * | 2016-01-25 | 2018-10-02 | Perkinelmer Health Sciences, Inc. | Method and system for microfluidic sample analysis |
WO2017164982A1 (en) * | 2016-03-21 | 2017-09-28 | The Regents Of The University Of California | Real-time and continuous measurement in vivo using aptamer-based biosensors |
US9892225B2 (en) * | 2016-04-01 | 2018-02-13 | International Business Machines Corporation | Method for optimizing the design of micro-fluidic devices |
US11467156B2 (en) | 2016-06-01 | 2022-10-11 | Duke University | Nonfouling biosensors |
US10989724B1 (en) | 2016-07-29 | 2021-04-27 | Labrador Diagnostics Llc | Systems and methods for multi-analysis |
CN109996888A (zh) | 2016-09-23 | 2019-07-09 | 阿尔韦奥科技公司 | 用于检测分析物的方法和组合物 |
KR20190066620A (ko) * | 2016-10-07 | 2019-06-13 | 베링거잉겔하임베트메디카게엠베하 | 샘플을 테스트하기 위한 카트리지 및 분석 시스템 |
KR20190066622A (ko) * | 2016-10-07 | 2019-06-13 | 베링거잉겔하임베트메디카게엠베하 | 샘플을 테스트하기 위한 분석 시스템 및 방법 |
US10258741B2 (en) | 2016-12-28 | 2019-04-16 | Cequr Sa | Microfluidic flow restrictor and system |
US11648200B2 (en) | 2017-01-12 | 2023-05-16 | Duke University | Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly |
US11237161B2 (en) | 2017-01-25 | 2022-02-01 | Cue Health Inc. | Systems and methods for enhanced detection and quantification of analytes |
US11213819B2 (en) * | 2017-01-30 | 2022-01-04 | Noavaran Payesh Ani Salamat (AZSense) | Integrated patient monitor system |
US10600337B2 (en) | 2017-01-31 | 2020-03-24 | Bank Of America Corporation | Intelligent content parsing with synthetic speech and tangible braille production |
WO2018175489A1 (en) | 2017-03-21 | 2018-09-27 | Abbott Diabetes Care Inc. | Methods, devices and system for providing diabetic condition diagnosis and therapy |
EP4306803A3 (en) | 2017-03-31 | 2024-04-10 | Vaxxas Pty Limited | Device and method for coating surfaces |
JP2020513108A (ja) | 2017-04-07 | 2020-04-30 | イージーディエックス インコーポレイテッドEasyDx,Inc. | 臨床現場即時検査(poct)カートリッジ |
US20180292380A1 (en) * | 2017-04-07 | 2018-10-11 | Lifehealth, Llc | Multi-liquid quality calibration single-use cartridge |
WO2018213320A1 (en) | 2017-05-15 | 2018-11-22 | Duke University | Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents |
US11175128B2 (en) | 2017-06-13 | 2021-11-16 | Vaxxas Pty Limited | Quality control of substrate coatings |
WO2019006374A1 (en) | 2017-06-30 | 2019-01-03 | Duke University | ORDER AND DISORDER AS A DESIGN PRINCIPLE FOR STIMULI-SENSITIVE BIOPOLYMER NETWORKS |
KR102005493B1 (ko) * | 2017-08-03 | 2019-10-08 | 한국전자통신연구원 | 얼굴 표정 교정 장치 및 이를 사용한 바이오 물질 분석 방법 |
AU2018309562A1 (en) | 2017-08-04 | 2020-02-20 | Vaxxas Pty Limited | Compact high mechanical energy storage and low trigger force actuator for the delivery of microprojection array patches (MAP) |
WO2019045807A1 (en) | 2017-08-31 | 2019-03-07 | Biofire Defense, Llc. | ANALYSIS DEVICES AND METHODS OF USE |
EP3459632A1 (en) * | 2017-09-26 | 2019-03-27 | Lunaphore Technologies SA | Microfluidic cartrige with built-in sampling device |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
CN111246797A (zh) | 2017-10-24 | 2020-06-05 | 德克斯康公司 | 预连接分析物传感器 |
US11733323B2 (en) * | 2018-06-13 | 2023-08-22 | Centrul International De Biodinamica | Systems and methods for measuring cellular response to target analytes by controlled application of an oscillating stimulus |
EP3829622A4 (en) | 2018-08-02 | 2022-05-11 | Duke University | DUAL AGONIST FUSION PROTEINS |
AU2019352901A1 (en) | 2018-10-02 | 2021-05-27 | WearOptimo Pty Ltd | Measurement system |
WO2020069567A1 (en) | 2018-10-02 | 2020-04-09 | WearOptimo Pty Ltd | Electrode arrangement |
US20220163543A1 (en) * | 2019-03-04 | 2022-05-26 | Siemens Healthcare Diagnostics Inc. | Dried reagent polysaccharide surface area stabilization |
CA3133975A1 (en) * | 2019-03-18 | 2020-09-24 | Siemens Healthcare Diagnostics Inc. | Diagnostic consumables incorporating coated micro-projection arrays, and methods thereof |
US11512314B2 (en) | 2019-07-12 | 2022-11-29 | Duke University | Amphiphilic polynucleotides |
CN110736540B (zh) * | 2019-09-18 | 2021-06-22 | 中国科学院合肥物质科学研究院 | 一种266nm泵浦的相关光子自校准太阳光谱辐照度仪 |
US20220338744A1 (en) | 2019-09-27 | 2022-10-27 | Cardiorenal | Overall loop system |
EP4078186A4 (en) * | 2019-12-20 | 2024-01-17 | 1000519753 Ontario Inc | DEVICES AND METHODS FOR QUANTIFYING FATTY ACIDS |
WO2021142439A1 (en) * | 2020-01-09 | 2021-07-15 | The Regents Of The University Of Michigan | Device for rapid and quantitative detection of drugs of abuse in sweat |
TWI758797B (zh) * | 2020-07-28 | 2022-03-21 | 長庚大學 | 應用於生物表面檢測之裝置及方法 |
KR102474238B1 (ko) * | 2020-09-14 | 2022-12-06 | (주) 비비비 | 생체시료 분석용 카트리지 및 이를 이용한 생체시료 분석 시스템 |
WO2022109390A1 (en) * | 2020-11-22 | 2022-05-27 | Gattaco Inc. | Sample transfer devices, and components and methods thereof |
EP4016068A1 (en) * | 2020-12-21 | 2022-06-22 | F. Hoffmann-La Roche AG | Sensor assembly |
WO2022204107A1 (en) * | 2021-03-23 | 2022-09-29 | Janssen Biotech, Inc | Multiparameter materials, methods and systems for bioreactor glycated species manufacture |
CN117098996A (zh) * | 2021-03-31 | 2023-11-21 | 美国血液技术公司 | 止血测量装置质量控制制剂 |
WO2022221618A1 (en) * | 2021-04-16 | 2022-10-20 | New York University | Bone marrow on a chip |
AU2022305241A1 (en) * | 2021-07-01 | 2024-01-25 | Bluebird Bio, Inc. | Methods |
GB2622645A (en) * | 2022-09-26 | 2024-03-27 | Tachmed Holdings Ltd | System |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5961451A (en) * | 1997-04-07 | 1999-10-05 | Motorola, Inc. | Noninvasive apparatus having a retaining member to retain a removable biosensor |
US20020120183A1 (en) * | 2001-02-15 | 2002-08-29 | Klaus Abraham-Fuchs | Network for evaluating data obtained in a biochip measurement device |
Family Cites Families (460)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4022A (en) * | 1845-05-01 | Improvement in machines for hackling and cleaning hemp and flax | ||
US2842787A (en) * | 1955-10-24 | 1958-07-15 | Maglin Inc | Loading ramp |
JPS5036087A (zh) | 1973-07-13 | 1975-04-04 | ||
US4146029A (en) | 1974-04-23 | 1979-03-27 | Ellinwood Jr Everett H | Self-powered implanted programmable medication system and method |
US4003379A (en) * | 1974-04-23 | 1977-01-18 | Ellinwood Jr Everett H | Apparatus and method for implanted self-powered medication dispensing |
US4347176A (en) * | 1980-04-14 | 1982-08-31 | Burroughs Wellcome Co. | Compounds and methods of making same |
FR2498331A1 (fr) | 1981-01-20 | 1982-07-23 | Kadouche Jean | Recipient reactif pour analyse notamment immunologique |
GB8422876D0 (en) | 1984-09-11 | 1984-10-17 | Secr Defence | Silicon implant devices |
US4920213A (en) | 1985-06-20 | 1990-04-24 | Biotechnology Research Partners, Ltd. | Method and compositions useful in preventing equine influenza |
US5204525A (en) * | 1985-08-05 | 1993-04-20 | Biotrack | Capillary flow device |
JPS6247555A (ja) | 1985-08-23 | 1987-03-02 | エフ.ホフマン ― ラ ロシュ アーゲー | シンチレ−シヨン近接定量法 |
US4731726A (en) * | 1986-05-19 | 1988-03-15 | Healthware Corporation | Patient-operated glucose monitor and diabetes management system |
US4935346A (en) * | 1986-08-13 | 1990-06-19 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
US5322770A (en) | 1989-12-22 | 1994-06-21 | Hoffman-Laroche Inc. | Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription |
US5310652A (en) | 1986-08-22 | 1994-05-10 | Hoffman-La Roche Inc. | Reverse transcription with thermostable DNA polymerase-high temperature reverse transcription |
US4902969A (en) * | 1987-06-01 | 1990-02-20 | Reliability Incorporated | Automated burn-in system |
US4946795A (en) | 1987-08-27 | 1990-08-07 | Biotrack, Inc. | Apparatus and method for dilution and mixing of liquid samples |
US4910131A (en) | 1987-12-23 | 1990-03-20 | Mellman Ira S | Idiotype and anti-idiotype antibodies useful in virus detection |
US5162237A (en) | 1988-04-11 | 1992-11-10 | Miles Inc. | Reaction cassette for preforming sequential analytical assays by noncentrifugal and noncapillary manipulations |
US5130238A (en) | 1988-06-24 | 1992-07-14 | Cangene Corporation | Enhanced nucleic acid amplification process |
US5132086A (en) | 1990-02-06 | 1992-07-21 | Chemtrak Corporation | Non-instrumented cholesterol assay |
US5104813A (en) * | 1989-04-13 | 1992-04-14 | Biotrack, Inc. | Dilution and mixing cartridge |
US5039617A (en) * | 1989-04-20 | 1991-08-13 | Biotrack, Inc. | Capillary flow device and method for measuring activated partial thromboplastin time |
WO1990013668A1 (en) | 1989-05-05 | 1990-11-15 | Lifecodes Corporation | Method for genetic analysis of a nucleic acid sample |
US5504007A (en) | 1989-05-19 | 1996-04-02 | Becton, Dickinson And Company | Rapid thermal cycle apparatus |
EP0731175A3 (en) | 1989-07-11 | 2004-05-26 | Gen-Probe Incorporated | Oligonucleotide probes for HIV nucleic acid |
CA2020958C (en) | 1989-07-11 | 2005-01-11 | Daniel L. Kacian | Nucleic acid sequence amplification methods |
US5089229A (en) | 1989-11-22 | 1992-02-18 | Vettest S.A. | Chemical analyzer |
US6176962B1 (en) | 1990-02-28 | 2001-01-23 | Aclara Biosciences, Inc. | Methods for fabricating enclosed microchannel structures |
US5242606A (en) | 1990-06-04 | 1993-09-07 | Abaxis, Incorporated | Sample metering port for analytical rotor having overflow chamber |
US5122284A (en) | 1990-06-04 | 1992-06-16 | Abaxis, Inc. | Apparatus and method for optically analyzing biological fluids |
US5061381A (en) | 1990-06-04 | 1991-10-29 | Abaxis, Inc. | Apparatus and method for separating cells from biological fluids |
US5173193A (en) | 1991-04-01 | 1992-12-22 | Schembri Carol T | Centrifugal rotor having flow partition |
US5527670A (en) | 1990-09-12 | 1996-06-18 | Scientific Generics Limited | Electrochemical denaturation of double-stranded nucleic acid |
DE69125441T2 (de) | 1990-09-28 | 1997-11-06 | Toshiba Kawasaki Kk | Verfahren zum Gennachweis |
TW279133B (zh) | 1990-12-13 | 1996-06-21 | Elan Med Tech | |
DE4041905A1 (de) | 1990-12-27 | 1992-07-02 | Boehringer Mannheim Gmbh | Testtraeger-analysesystem |
US5455166A (en) | 1991-01-31 | 1995-10-03 | Becton, Dickinson And Company | Strand displacement amplification |
US5273905A (en) | 1991-02-22 | 1993-12-28 | Amoco Corporation | Processing of slide mounted material |
US5264184A (en) | 1991-03-19 | 1993-11-23 | Minnesota Mining And Manufacturing Company | Device and a method for separating liquid samples |
US5279607A (en) * | 1991-05-30 | 1994-01-18 | The State University Of New York | Telemetry capsule and process |
FR2679661B1 (fr) | 1991-07-26 | 1994-10-14 | Sfri | Appareil d'analyse automatique d'echantillons. |
EP0541340B1 (en) | 1991-11-05 | 1997-07-16 | The Perkin-Elmer Corporation | Biopolymer synthesis apparatus and method |
US5270184A (en) | 1991-11-19 | 1993-12-14 | Becton, Dickinson And Company | Nucleic acid target generation |
US5288390A (en) | 1992-03-30 | 1994-02-22 | Sun Company, Inc. (R&M) | Polycyclic aromatic ring cleavage (PARC) process |
WO1993019827A1 (en) | 1992-04-02 | 1993-10-14 | Abaxis, Inc. | Analytical rotor with dye mixing chamber |
US5744366A (en) * | 1992-05-01 | 1998-04-28 | Trustees Of The University Of Pennsylvania | Mesoscale devices and methods for analysis of motile cells |
EP0637996B1 (en) | 1992-05-01 | 1997-07-23 | The Trustees Of The University Of Pennsylvania | Microfabricated detection structures |
US5380487A (en) | 1992-05-05 | 1995-01-10 | Pasteur Sanofi Diagnostics | Device for automatic chemical analysis |
US5357953A (en) | 1992-05-21 | 1994-10-25 | Puritan-Bennett Corporation | Measurement device and method of calibration |
US5318557A (en) | 1992-07-13 | 1994-06-07 | Elan Medical Technologies Limited | Medication administering device |
US5958339A (en) | 1992-08-31 | 1999-09-28 | Clinical Diagnostic Systems, Inc. | Format for immunoassay in thin film |
DK0660936T3 (da) | 1992-09-14 | 1999-05-25 | Stanford Res Inst Int | Op-konverterende reportermolekyle til biologiske og andre assays under anvendelse af laserexcitationsteknik |
US5674698A (en) * | 1992-09-14 | 1997-10-07 | Sri International | Up-converting reporters for biological and other assays using laser excitation techniques |
US5951300A (en) | 1997-03-10 | 1999-09-14 | Health Hero Network | Online system and method for providing composite entertainment and health information |
US5478750A (en) | 1993-03-31 | 1995-12-26 | Abaxis, Inc. | Methods for photometric analysis |
JP3563140B2 (ja) | 1995-01-19 | 2004-09-08 | 株式会社日立製作所 | キャピラリーアレイ電気泳動装置 |
KR960703174A (ko) | 1993-06-09 | 1996-06-19 | 미안 알렉 | 자기장 순환식 반응방법(magnetic cycle reaction) |
US5578269A (en) | 1993-06-11 | 1996-11-26 | Ortho Diagnostic Systems Inc. | Automated blood analysis system with an integral centrifuge |
EP0631137B1 (en) | 1993-06-25 | 2002-03-20 | Edward W. Stark | Glucose related measurement method and apparatus |
JP3343156B2 (ja) | 1993-07-14 | 2002-11-11 | アークレイ株式会社 | 光学式成分濃度測定装置および方法 |
GB9315671D0 (en) | 1993-07-29 | 1993-09-15 | Dow Corning Sa | Foam control agents and their use |
DE69430954T2 (de) | 1993-08-13 | 2003-03-13 | Albany Molecular Res Inc | Biokatalytische metoden zum synthetisieren und identifizieren biologisch aktive verbindungen |
US5397709A (en) | 1993-08-27 | 1995-03-14 | Becton Dickinson And Company | System for detecting bacterial growth in a plurality of culture vials |
CA2129787A1 (en) | 1993-08-27 | 1995-02-28 | Russell G. Higuchi | Monitoring multiple amplification reactions simultaneously and analyzing same |
US5591643A (en) | 1993-09-01 | 1997-01-07 | Abaxis, Inc. | Simplified inlet channels |
US6235531B1 (en) | 1993-09-01 | 2001-05-22 | Abaxis, Inc. | Modified siphons for improved metering precision |
EP1028320B1 (en) | 1993-09-24 | 2006-03-01 | Abbott Laboratories | Method of operating an automated, continuous and random access analytical system capable of simultaneously effecting multiple assays in a plurality of liquid samples |
JP3391862B2 (ja) | 1993-10-05 | 2003-03-31 | 株式会社日立製作所 | クロマトグラム解析方法 |
JPH07120393A (ja) | 1993-10-13 | 1995-05-12 | Nippon Tectron Co Ltd | 蛍光検出法 |
EP0887867B1 (en) | 1993-11-02 | 2004-04-21 | Matsushita Electric Industrial Co., Ltd | Semiconductor device comprising an aggregate of semiconductor micro-needles |
US5403415A (en) | 1993-11-17 | 1995-04-04 | Abaxis, Inc. | Method and device for ultrasonic welding |
JPH07151101A (ja) | 1993-11-29 | 1995-06-13 | Kazuo Sugimura | ダイヤフラム接触面が渦巻状の容器 |
JP3504750B2 (ja) | 1993-12-22 | 2004-03-08 | オルソ−クリニカル ダイアグノスティクス,インコーポレイティド | 検量関係式の再校正法及び定量試験キット |
JPH07196314A (ja) | 1993-12-28 | 1995-08-01 | Maruo Calcium Co Ltd | チューブ状合成無機微粒子 |
US6033850A (en) | 1994-03-15 | 2000-03-07 | Affymetrix, Inc. | Electrochemical denaturation of double-stranded nucleic acid |
US5590052A (en) | 1994-04-14 | 1996-12-31 | Abaxis, Inc. | Error checking in blood analyzer |
US5648211A (en) | 1994-04-18 | 1997-07-15 | Becton, Dickinson And Company | Strand displacement amplification using thermophilic enzymes |
JP3584990B2 (ja) | 1994-05-09 | 2004-11-04 | タカラバイオ株式会社 | 抗ヒトインフルエンザウイルス抗体 |
US5624850A (en) | 1994-06-06 | 1997-04-29 | Idetek, Inc. | Immunoassays in capillaries |
US5976896A (en) | 1994-06-06 | 1999-11-02 | Idexx Laboratories, Inc. | Immunoassays in capillary tubes |
US6403367B1 (en) | 1994-07-07 | 2002-06-11 | Nanogen, Inc. | Integrated portable biological detection system |
JP2637695B2 (ja) | 1994-07-12 | 1997-08-06 | 株式会社バイオセンサー研究所 | 溶液吸引器具および吸引式溶液内微量物質測定装置 |
US5639428A (en) | 1994-07-19 | 1997-06-17 | Becton Dickinson And Company | Method and apparatus for fully automated nucleic acid amplification, nucleic acid assay and immunoassay |
US5891734A (en) | 1994-08-01 | 1999-04-06 | Abbott Laboratories | Method for performing automated analysis |
US6001229A (en) | 1994-08-01 | 1999-12-14 | Lockheed Martin Energy Systems, Inc. | Apparatus and method for performing microfluidic manipulations for chemical analysis |
JP3652424B2 (ja) | 1994-10-27 | 2005-05-25 | 日本政策投資銀行 | 自動分析装置及びその方法 |
IE72524B1 (en) | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
FI101829B1 (fi) * | 1995-03-07 | 1998-08-31 | Erkki Juhani Soini | Biospesifinen määritysmenetelmä |
US5557596A (en) | 1995-03-20 | 1996-09-17 | Gibson; Gary | Ultra-high density storage device |
US6340588B1 (en) | 1995-04-25 | 2002-01-22 | Discovery Partners International, Inc. | Matrices with memories |
US6352854B1 (en) * | 1995-04-25 | 2002-03-05 | Discovery Partners International, Inc. | Remotely programmable matrices with memories |
US5961923A (en) * | 1995-04-25 | 1999-10-05 | Irori | Matrices with memories and uses thereof |
US6319668B1 (en) * | 1995-04-25 | 2001-11-20 | Discovery Partners International | Method for tagging and screening molecules |
US5874214A (en) | 1995-04-25 | 1999-02-23 | Irori | Remotely programmable matrices with memories |
US5832296A (en) | 1995-04-26 | 1998-11-03 | Interval Research Corp. | Wearable context sensitive user interface for interacting with plurality of electronic devices of interest to the user |
JP3839524B2 (ja) | 1995-06-07 | 2006-11-01 | アジレント・テクノロジーズ・インク | 小型化全分析システム |
US5716852A (en) * | 1996-03-29 | 1998-02-10 | University Of Washington | Microfabricated diffusion-based chemical sensor |
US6168948B1 (en) | 1995-06-29 | 2001-01-02 | Affymetrix, Inc. | Miniaturized genetic analysis systems and methods |
JP3927570B2 (ja) | 1995-07-31 | 2007-06-13 | プレシジョン・システム・サイエンス株式会社 | 容器 |
US6299839B1 (en) | 1995-08-31 | 2001-10-09 | First Medical, Inc. | System and methods for performing rotor assays |
JPH0968533A (ja) | 1995-08-31 | 1997-03-11 | Brother Ind Ltd | 薬品投与量を表示可能な生化学物質測定装置 |
JP3515646B2 (ja) | 1995-09-18 | 2004-04-05 | 大塚電子株式会社 | マルチキャピラリ電気泳動装置 |
JPH09113511A (ja) | 1995-10-18 | 1997-05-02 | Kdk Corp | グリコアルブミン測定用乾式試験片 |
US5687716A (en) | 1995-11-15 | 1997-11-18 | Kaufmann; Peter | Selective differentiating diagnostic process based on broad data bases |
US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
JPH09192218A (ja) | 1996-01-16 | 1997-07-29 | Hitachi Ltd | 血糖値管理システム |
DE19601487C2 (de) * | 1996-01-17 | 2001-09-13 | Micronas Gmbh | Vorrichtung zum Behandeln von malignen Gewebsveränderungen |
US5863502A (en) | 1996-01-24 | 1999-01-26 | Sarnoff Corporation | Parallel reaction cassette and associated devices |
CN1096185C (zh) | 1996-01-27 | 2002-12-11 | 三星电子株式会社 | 使用运动和空间相关的隔行向逐行转换装置和方法 |
US5670375A (en) | 1996-02-21 | 1997-09-23 | Biomerieux Vitek, Inc. | Sample card transport method for biological sample testing machine |
US20010044588A1 (en) * | 1996-02-22 | 2001-11-22 | Mault James R. | Monitoring system |
ES2197330T3 (es) | 1996-03-01 | 2004-01-01 | Biota Scientific Management Pty. Ltd. | Metodo para detectar el virus de gripe y compuestos para emplear en el. |
JP2988362B2 (ja) | 1996-03-11 | 1999-12-13 | 株式会社日立製作所 | 多検体分析システム |
JPH09244055A (ja) | 1996-03-14 | 1997-09-19 | Hitachi Ltd | 液晶表示装置 |
US5801057A (en) * | 1996-03-22 | 1998-09-01 | Smart; Wilson H. | Microsampling device and method of construction |
JP2783277B2 (ja) | 1996-03-27 | 1998-08-06 | 日本電気株式会社 | 患者監視装置及び患者監視システム |
JPH09281078A (ja) | 1996-04-09 | 1997-10-31 | Hitachi Electron Eng Co Ltd | Dna塩基配列決定装置 |
US5942443A (en) * | 1996-06-28 | 1999-08-24 | Caliper Technologies Corporation | High throughput screening assay systems in microscale fluidic devices |
US5885470A (en) | 1997-04-14 | 1999-03-23 | Caliper Technologies Corporation | Controlled fluid transport in microfabricated polymeric substrates |
JP3213566B2 (ja) | 1996-04-26 | 2001-10-02 | アークレイ株式会社 | 検体分析用具およびそれを用いた検体分析方法並びに検体分析装置 |
US5980830A (en) | 1996-05-20 | 1999-11-09 | Sendx Medical, Inc. | Portable modular blood analyzer with simplified fluid handling sequence |
IL118432A (en) | 1996-05-27 | 1999-12-31 | Yissum Res Dev Co | Electrochemical and photochemical electrodes and their use |
US5939291A (en) | 1996-06-14 | 1999-08-17 | Sarnoff Corporation | Microfluidic method for nucleic acid amplification |
NZ333346A (en) * | 1996-06-28 | 2000-03-27 | Caliper Techn Corp | High-throughput screening assay systems in microscale fluidic devices |
US5797898A (en) * | 1996-07-02 | 1998-08-25 | Massachusetts Institute Of Technology | Microchip drug delivery devices |
EP0818547A1 (en) | 1996-07-10 | 1998-01-14 | Autoliv ASP, Inc. | Recovery of metals values from air bag inflators |
US5874046A (en) | 1996-10-30 | 1999-02-23 | Raytheon Company | Biological warfare agent sensor system employing ruthenium-terminated oligonucleotides complementary to target live agent DNA sequences |
GB9624096D0 (en) | 1996-11-20 | 1997-01-08 | Microbial Systems Ltd | Apparatus and method of use thereof |
US6071251A (en) | 1996-12-06 | 2000-06-06 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
US7590549B2 (en) * | 1996-12-23 | 2009-09-15 | Health Hero Network, Inc. | Network media access control system for encouraging patient compliance with a treatment plan |
ATE227844T1 (de) * | 1997-02-06 | 2002-11-15 | Therasense Inc | Kleinvolumiger sensor zur in-vitro bestimmung |
JPH10239240A (ja) | 1997-02-25 | 1998-09-11 | Hitachi Ltd | 自動dnaプローブ装置 |
US8293064B2 (en) | 1998-03-02 | 2012-10-23 | Cepheid | Method for fabricating a reaction vessel |
AU6343398A (en) | 1997-02-28 | 1998-09-18 | Cepheid | Heat exchanging, optically interrogated chemical reaction assembly |
JP3393361B2 (ja) | 1997-03-24 | 2003-04-07 | 国立身体障害者リハビリテーションセンター総長 | バイオセンサ |
GB9706654D0 (en) | 1997-04-02 | 1997-05-21 | Scient Generics Ltd | Disassociation of interacting molecules |
US6235471B1 (en) | 1997-04-04 | 2001-05-22 | Caliper Technologies Corp. | Closed-loop biochemical analyzers |
CA2256563A1 (en) | 1997-04-04 | 1998-10-15 | Innogenetics N.V. | Isothermal polymerase chain reaction by cycling the concentration of divalent metal ions |
US6391622B1 (en) * | 1997-04-04 | 2002-05-21 | Caliper Technologies Corp. | Closed-loop biochemical analyzers |
DE19717023C2 (de) * | 1997-04-23 | 2003-02-06 | Micronas Gmbh | Vorrichtung zum Behandeln von malignen, tumorösen Gewebebereichen |
AU727083B2 (en) | 1997-04-25 | 2000-11-30 | Caliper Life Sciences, Inc. | Microfluidic devices incorporating improved channel geometries |
US6406845B1 (en) | 1997-05-05 | 2002-06-18 | Trustees Of Tuft College | Fiber optic biosensor for selectively detecting oligonucleotide species in a mixed fluid sample |
JPH10305016A (ja) | 1997-05-08 | 1998-11-17 | Casio Comput Co Ltd | 行動情報提供システム |
US5985214A (en) | 1997-05-16 | 1999-11-16 | Aurora Biosciences Corporation | Systems and methods for rapidly identifying useful chemicals in liquid samples |
DE69831830T2 (de) | 1997-06-09 | 2006-06-22 | F. Hoffmann-La Roche Ag | Einweg-Analysevorrichtung |
US6524790B1 (en) * | 1997-06-09 | 2003-02-25 | Caliper Technologies Corp. | Apparatus and methods for correcting for variable velocity in microfluidic systems |
JPH115756A (ja) | 1997-06-16 | 1999-01-12 | Mitsubishi Chem Corp | 2−アルキルアズレン類の製造方法 |
CA2294294A1 (en) | 1997-07-14 | 1999-01-28 | Abbott Laboratories | Telemedicine |
US5876675A (en) | 1997-08-05 | 1999-03-02 | Caliper Technologies Corp. | Microfluidic devices and systems |
US6368871B1 (en) | 1997-08-13 | 2002-04-09 | Cepheid | Non-planar microstructures for manipulation of fluid samples |
JPH1157560A (ja) | 1997-08-27 | 1999-03-02 | Shin Meiwa Ind Co Ltd | 液体散布車 |
JP2001518624A (ja) | 1997-09-26 | 2001-10-16 | ユニバーシティ・オブ・ワシントン | 同時の粒子分離および化学反応 |
US5842787A (en) | 1997-10-09 | 1998-12-01 | Caliper Technologies Corporation | Microfluidic systems incorporating varied channel dimensions |
FI107080B (fi) | 1997-10-27 | 2001-05-31 | Nokia Mobile Phones Ltd | Mittauslaite |
US6174675B1 (en) | 1997-11-25 | 2001-01-16 | Caliper Technologies Corp. | Electrical current for controlling fluid parameters in microchannels |
EP1179585B1 (en) | 1997-12-24 | 2008-07-09 | Cepheid | Device and method for lysis |
US6074616A (en) * | 1998-01-05 | 2000-06-13 | Biosite Diagnostics, Inc. | Media carrier for an assay device |
US6200814B1 (en) * | 1998-01-20 | 2001-03-13 | Biacore Ab | Method and device for laminar flow on a sensing surface |
US6861035B2 (en) * | 1998-02-24 | 2005-03-01 | Aurora Discovery, Inc. | Multi-well platforms, caddies, lids and combinations thereof |
US6369893B1 (en) | 1998-05-19 | 2002-04-09 | Cepheid | Multi-channel optical detection system |
US6929953B1 (en) | 1998-03-07 | 2005-08-16 | Robert A. Levine | Apparatus for analyzing biologic fluids |
US6663833B1 (en) | 1998-03-10 | 2003-12-16 | Strategic Diagnostics Inc. | Integrated assay device and methods of production and use |
US6979424B2 (en) | 1998-03-17 | 2005-12-27 | Cepheid | Integrated sample analysis device |
US7188001B2 (en) | 1998-03-23 | 2007-03-06 | Cepheid | System and method for temperature control |
US6200531B1 (en) | 1998-05-11 | 2001-03-13 | Igen International, Inc. | Apparatus for carrying out electrochemiluminescence test measurements |
EP1046032A4 (en) * | 1998-05-18 | 2002-05-29 | Univ Washington | LIQUID ANALYSIS CARTRIDGE |
US6287765B1 (en) | 1998-05-20 | 2001-09-11 | Molecular Machines, Inc. | Methods for detecting and identifying single molecules |
EP0962773A1 (en) | 1998-06-03 | 1999-12-08 | Mark Howard Jones | Electrochemical based assay processes instrument and labels |
US6503231B1 (en) * | 1998-06-10 | 2003-01-07 | Georgia Tech Research Corporation | Microneedle device for transport of molecules across tissue |
JP3389106B2 (ja) | 1998-06-11 | 2003-03-24 | 松下電器産業株式会社 | 電気化学分析素子 |
US7799521B2 (en) * | 1998-06-24 | 2010-09-21 | Chen & Chen, Llc | Thermal cycling |
US6780617B2 (en) | 2000-12-29 | 2004-08-24 | Chen & Chen, Llc | Sample processing device and method |
US6743605B1 (en) | 1998-06-24 | 2004-06-01 | Enzo Life Sciences, Inc. | Linear amplification of specific nucleic acid sequences |
EP1192089A1 (en) | 1998-07-06 | 2002-04-03 | The Coca-Cola Company | Basket with integrally-formed receptacle |
US6214629B1 (en) | 1998-08-06 | 2001-04-10 | Spectral Diagnostics, Inc. | Analytical test device and method for use in medical diagnoses |
US6344333B2 (en) | 1998-09-08 | 2002-02-05 | Synectig Corporation | Reagent-free immunoassay monitoring electrode assembly |
EP2287338B1 (en) | 1998-11-09 | 2012-09-05 | Eiken Kagaku Kabushiki Kaisha | Process for synthesizing nucleic acid |
US6602469B1 (en) | 1998-11-09 | 2003-08-05 | Lifestream Technologies, Inc. | Health monitoring and diagnostic device and network-based health assessment and medical records maintenance system |
US7914994B2 (en) | 1998-12-24 | 2011-03-29 | Cepheid | Method for separating an analyte from a sample |
US6887693B2 (en) | 1998-12-24 | 2005-05-03 | Cepheid | Device and method for lysing cells, spores, or microorganisms |
US6490030B1 (en) | 1999-01-18 | 2002-12-03 | Verification Technologies, Inc. | Portable product authentication device |
US6542717B1 (en) * | 1999-01-20 | 2003-04-01 | International Business Machines Corporation | System and method for optimizing personal area network (PAN) electrostatic communication |
GB9903906D0 (en) | 1999-02-19 | 1999-04-14 | Microbiological Res Authority | Method and apparatus for nucleic acid strand separation |
AU769471B2 (en) | 1999-02-23 | 2004-01-29 | Cdx Laboratories, Inc. | Minimally invasive apparatus and method for testing lesions of the oral cavity and similar epithelium |
US6360888B1 (en) * | 1999-02-25 | 2002-03-26 | Minimed Inc. | Glucose sensor package system |
US6215894B1 (en) * | 1999-02-26 | 2001-04-10 | General Scanning, Incorporated | Automatic imaging and analysis of microarray biochips |
US8636648B2 (en) | 1999-03-01 | 2014-01-28 | West View Research, Llc | Endoscopic smart probe |
WO2000052446A1 (en) | 1999-03-02 | 2000-09-08 | Qualigen, Inc. | Methods and apparatus for separation of biological fluids |
EP1127611A3 (en) | 1999-03-03 | 2001-11-07 | Symyx Technologies, Inc. | Chemical processing microsystems with integrated, separation-based reaction product analysis |
US6464687B1 (en) | 1999-03-09 | 2002-10-15 | Ball Semiconductor, Inc. | Implantable drug delivery system |
US6305804B1 (en) | 1999-03-25 | 2001-10-23 | Fovioptics, Inc. | Non-invasive measurement of blood component using retinal imaging |
WO2001054813A2 (en) | 2000-01-11 | 2001-08-02 | Clinical Micro Sensors, Inc. | Devices and methods for biochip multiplexing |
US20040053290A1 (en) * | 2000-01-11 | 2004-03-18 | Terbrueggen Robert Henry | Devices and methods for biochip multiplexing |
US20020177135A1 (en) * | 1999-07-27 | 2002-11-28 | Doung Hau H. | Devices and methods for biochip multiplexing |
US6942771B1 (en) * | 1999-04-21 | 2005-09-13 | Clinical Micro Sensors, Inc. | Microfluidic systems in the electrochemical detection of target analytes |
JP4085514B2 (ja) | 1999-04-30 | 2008-05-14 | 株式会社島津製作所 | 電気泳動チップ |
US7001725B2 (en) | 1999-04-30 | 2006-02-21 | Aclara Biosciences, Inc. | Kits employing generalized target-binding e-tag probes |
MXPA01011429A (es) | 1999-05-11 | 2003-09-10 | Ortho Mcneil Pharm Inc | Modelado farmacocinetico y farmacodinamico de administracion de eritropoyetina. |
US6582964B1 (en) * | 1999-05-12 | 2003-06-24 | Cme Telemetrix Inc. | Method and apparatus for rapid measurement of HbA1c |
US6544732B1 (en) | 1999-05-20 | 2003-04-08 | Illumina, Inc. | Encoding and decoding of array sensors utilizing nanocrystals |
JP4495866B2 (ja) * | 1999-05-28 | 2010-07-07 | セフィード | 化学反応を制御するためのカートリッジ |
CA2374423C (en) | 1999-05-28 | 2013-04-09 | Cepheid | Apparatus and method for analyzing a liquid sample |
US6818185B1 (en) | 1999-05-28 | 2004-11-16 | Cepheid | Cartridge for conducting a chemical reaction |
WO2000073799A1 (en) | 1999-06-01 | 2000-12-07 | Caliper Technologies Corp. | Microscale assays and microfluidic devices for transporter, gradient induced, and binding activities |
US6256533B1 (en) * | 1999-06-09 | 2001-07-03 | The Procter & Gamble Company | Apparatus and method for using an intracutaneous microneedle array |
ATE254963T1 (de) | 1999-06-22 | 2003-12-15 | Agilent Technologies Inc | Apparat zum betrieb eines mikrofluidischen gerätes |
US7195670B2 (en) * | 2000-06-27 | 2007-03-27 | California Institute Of Technology | High throughput screening of crystallization of materials |
US6353475B1 (en) | 1999-07-12 | 2002-03-05 | Caliper Technologies Corp. | Light source power modulation for use with chemical and biochemical analysis |
US6514769B2 (en) * | 1999-07-29 | 2003-02-04 | Jin Po Lee | Multiple analyte assay device with sample integrity monitoring system |
ATE364843T1 (de) | 1999-08-11 | 2007-07-15 | Asahi Chemical Ind | Analysenkassette und flüssigkeitsförderkontroller |
DE60018582T2 (de) | 1999-08-18 | 2006-01-19 | Microchips, Inc., Bedford | Thermisch aktivierbarer microchip als abgabevorrichtung für chemikalien |
JP2001065458A (ja) | 1999-08-25 | 2001-03-16 | Matsushita Electric Ind Co Ltd | 圧縮機 |
US6858185B1 (en) * | 1999-08-25 | 2005-02-22 | Caliper Life Sciences, Inc. | Dilutions in high throughput systems with a single vacuum source |
ES2283153T3 (es) | 1999-09-09 | 2007-10-16 | Nokia Corporation | Determinacion de la velocidad de datos, basada en estimaciones de la densidad espectral de potencia. |
US20030175993A1 (en) | 1999-09-10 | 2003-09-18 | Anthony Toranto | Ketone assay |
CN102586228A (zh) | 1999-09-13 | 2012-07-18 | 纽亘技术公司 | 用于多核苷酸序列线性等温扩增的方法及组合物 |
BR0014289A (pt) * | 1999-09-24 | 2002-07-02 | Ca Nat Research Council | Método e aparelho para realizar angiografia intra-operativa |
US6835184B1 (en) | 1999-09-24 | 2004-12-28 | Becton, Dickinson And Company | Method and device for abrading skin |
US6368275B1 (en) * | 1999-10-07 | 2002-04-09 | Acuson Corporation | Method and apparatus for diagnostic medical information gathering, hyperthermia treatment, or directed gene therapy |
WO2001026813A2 (en) * | 1999-10-08 | 2001-04-19 | Micronics, Inc. | Microfluidics without electrically of mechanically operated pumps |
JP3481578B2 (ja) | 1999-10-12 | 2003-12-22 | 松下電器産業株式会社 | 電子放出素子およびそれを利用した電子源、電界放出型画像表示装置、蛍光灯、並びにそれらの製造方法 |
US6471916B1 (en) * | 1999-11-09 | 2002-10-29 | Packard Instrument Company | Apparatus and method for calibration of a microarray scanning system |
US6361958B1 (en) * | 1999-11-12 | 2002-03-26 | Motorola, Inc. | Biochannel assay for hybridization with biomaterial |
EP2308522A3 (en) | 1999-11-17 | 2012-02-29 | Boston Scientific Limited | Microfabricated devices for the delivery of molecules into a carrier fluid |
JP3441058B2 (ja) | 1999-12-03 | 2003-08-25 | 理化学研究所 | キャピラリーゲル電気泳動用マイクロチップおよびその製造方法 |
JP2001165752A (ja) | 1999-12-06 | 2001-06-22 | Hitachi Ltd | 血清量測定装置および測定方法 |
GB9930000D0 (en) | 1999-12-21 | 2000-02-09 | Phaeton Research Ltd | An ingestible device |
WO2001053792A2 (en) * | 2000-01-19 | 2001-07-26 | Given Imaging Ltd. | A system for detecting substances |
AU2001247195A1 (en) * | 2000-01-31 | 2001-08-07 | Board Of Regents, The University Of Texas System | Method and system for collecting and transmitting chemical information |
US7039453B2 (en) | 2000-02-08 | 2006-05-02 | Tarun Mullick | Miniature ingestible capsule |
KR100542386B1 (ko) | 2000-02-15 | 2006-01-10 | 주식회사 신한은행 | 기업간 대금결제 관리 시스템 및 이를 이용한 기업간대금결제 관리 방법 |
US20030017467A1 (en) * | 2000-02-18 | 2003-01-23 | Aclara Biosciences, Inc. | Multiple-site sample-handling apparatus and method |
CA2399199A1 (en) * | 2000-02-23 | 2001-08-30 | Ring-Ling Chien | Multi-reservoir pressure control system |
ATE499988T1 (de) | 2000-03-02 | 2011-03-15 | Microchips Inc | Mikromechanische geräte und verfahren zur speicherung und zur selektiven exposition von chemikalien |
PT1261860E (pt) | 2000-03-09 | 2007-03-30 | Clinical Analysis Corp | Sistema de diagnóstico médico |
US6927851B2 (en) | 2000-03-31 | 2005-08-09 | Neogen Corporation | Methods and apparatus to improve the sensitivity and reproducibility of bioluminescent analytical methods |
AU2001252973A1 (en) | 2000-04-17 | 2001-10-30 | Purdue Research Foundation | Biosensor and related method |
US6413213B1 (en) | 2000-04-18 | 2002-07-02 | Roche Diagnostics Corporation | Subscription based monitoring system and method |
US20020052761A1 (en) | 2000-05-11 | 2002-05-02 | Fey Christopher T. | Method and system for genetic screening data collection, analysis, report generation and access |
US7006858B2 (en) | 2000-05-15 | 2006-02-28 | Silver James H | Implantable, retrievable sensors and immunosensors |
EP1284818B1 (en) | 2000-05-15 | 2006-11-22 | Tecan Trading AG | Bidirectional flow centrifugal microfluidic devices |
IL163684A0 (en) | 2000-05-31 | 2005-12-18 | Given Imaging Ltd | Measurement of electrical characteristics of tissue |
AU6501201A (en) * | 2000-06-01 | 2001-12-11 | Science Applic Int Corp | Systems and methods for monitoring health and delivering drugs transdermally |
US7641856B2 (en) * | 2004-05-14 | 2010-01-05 | Honeywell International Inc. | Portable sample analyzer with removable cartridge |
US8071051B2 (en) * | 2004-05-14 | 2011-12-06 | Honeywell International Inc. | Portable sample analyzer cartridge |
US7978329B2 (en) * | 2000-08-02 | 2011-07-12 | Honeywell International Inc. | Portable scattering and fluorescence cytometer |
WO2001093743A2 (en) | 2000-06-07 | 2001-12-13 | Healthetech, Inc. | Breath ketone analyzer |
US6540675B2 (en) * | 2000-06-27 | 2003-04-01 | Rosedale Medical, Inc. | Analyte monitor |
US6603987B2 (en) | 2000-07-11 | 2003-08-05 | Bayer Corporation | Hollow microneedle patch |
JP2002031055A (ja) | 2000-07-14 | 2002-01-31 | Matsushita Electric Ind Co Ltd | 密閉型圧縮機 |
WO2002007064A2 (en) | 2000-07-17 | 2002-01-24 | Labnetics, Inc. | Method and apparatus for the processing of remotely collected electronic information characterizing properties of biological entities |
AU2001277163A1 (en) * | 2000-07-24 | 2002-02-05 | Motorola, Inc. | Ingestible electronic capsule |
JP2002044007A (ja) | 2000-07-26 | 2002-02-08 | Ricoh Elemex Corp | 携帯電話機 |
US20040005582A1 (en) | 2000-08-10 | 2004-01-08 | Nanobiodynamics, Incorporated | Biospecific desorption microflow systems and methods for studying biospecific interactions and their modulators |
WO2002015778A1 (en) | 2000-08-18 | 2002-02-28 | Cygnus, Inc. | Analyte monitoring device alarm augmentation system |
US20020026111A1 (en) * | 2000-08-28 | 2002-02-28 | Neil Ackerman | Methods of monitoring glucose levels in a subject and uses thereof |
SG100731A1 (en) | 2000-08-30 | 2003-12-26 | Wardlaw Partners Lp | Container for holding biologic fluid for analysis |
ES2287156T3 (es) | 2000-09-08 | 2007-12-16 | Insulet Corporation | Dispositivos y sistemas para la infusion de un paciente. |
US7052831B2 (en) | 2000-09-29 | 2006-05-30 | Becton Dickinson And Company | Detection of multiple analytes from a single sample using a multi-well, multi-analyte flow-through diagnostic test device |
US20020187485A1 (en) | 2000-10-25 | 2002-12-12 | Jakobsen Mogens Hausteen | Open substrate platforms suitable for analysis of biomolecules |
CA2360194C (en) | 2000-10-25 | 2008-10-07 | Micronix, Inc. | A solid state microcuvette using dry films |
DK1201304T3 (da) | 2000-10-25 | 2006-11-13 | Boehringer Ingelheim Micropart | Mikrostruktureret platform til undersögelse af en væske |
US6929636B1 (en) * | 2000-11-08 | 2005-08-16 | Hewlett-Packard Development Company, L.P. | Internal drug dispenser capsule medical device |
JP2002161856A (ja) | 2000-11-28 | 2002-06-07 | Matsushita Electric Ind Co Ltd | シャフトおよびシャフトの製造方法 |
CA2430086A1 (en) | 2000-12-01 | 2002-06-06 | Cetek Corporation | High throughput capillary electrophoresis system |
US20050019836A1 (en) | 2000-12-06 | 2005-01-27 | Horst Vogel | Bioanalytical reagent, method for production thereof, sensor platforms and detection methods based on use of said bioanalytical reagent |
GB0030929D0 (en) | 2000-12-19 | 2001-01-31 | Inverness Medical Ltd | Analyte measurement |
WO2002059625A2 (en) * | 2000-12-26 | 2002-08-01 | Weigl Bernhard H | Microfluidic cartridge with integrated electronics |
US6870797B2 (en) | 2001-01-04 | 2005-03-22 | Hewlett-Packard Development Company, L.P. | Media storage system using a transponder for transmitting data signal |
US7435384B2 (en) * | 2001-01-08 | 2008-10-14 | Leonard Fish | Diagnostic instrument with movable electrode mounting member and methods for detecting analytes |
CA2366802A1 (en) | 2001-01-17 | 2002-07-17 | Bayer Corporation | Method and apparatus for using infrared readings to detect misidentification of a diagnostic test strip in a reflectance spectrometer |
CA2435205A1 (en) | 2001-01-22 | 2002-08-01 | V-Target Technologies Ltd. | Ingestible device |
US6878755B2 (en) | 2001-01-22 | 2005-04-12 | Microgen Systems, Inc. | Automated microfabrication-based biodetector |
US6484104B2 (en) | 2001-02-15 | 2002-11-19 | Klaus Abraham-Fuchs | Network for evaluating data obtained in a biochip measurement device |
US7567913B2 (en) | 2001-02-16 | 2009-07-28 | Quest Diagnostics Inc. | Method and system for ordering a laboratory test for a patient and obtaining results thereof |
US6612985B2 (en) | 2001-02-26 | 2003-09-02 | University Of Rochester | Method and system for monitoring and treating a patient |
US20020168663A1 (en) * | 2001-02-27 | 2002-11-14 | Phan Brigitte Chau | Methods for DNA conjugation onto solid phase including related optical biodiscs and disc drive systems |
US6949377B2 (en) * | 2001-03-05 | 2005-09-27 | Ho Winston Z | Chemiluminescence-based microfluidic biochip |
JP2002266762A (ja) | 2001-03-07 | 2002-09-18 | Matsushita Electric Ind Co Ltd | 冷凍サイクル装置 |
BR0205268A (pt) | 2001-03-09 | 2004-11-30 | Nugen Technologies Inc | Processos e composições para a mplificação de sequências de rna |
JP2002263185A (ja) | 2001-03-12 | 2002-09-17 | Sanyo Electric Co Ltd | 投薬システム及び方法及び投薬装置 |
US6748337B2 (en) | 2001-03-14 | 2004-06-08 | Wardlaw Partners, Lp | Method and apparatus for providing quality control in an instrument for medical analysis |
WO2002075312A1 (en) | 2001-03-19 | 2002-09-26 | Gyros Ab | Characterization of reaction variables |
JP2002282217A (ja) | 2001-03-27 | 2002-10-02 | Sysmex Corp | 測定装置及びそれを含む測定結果管理システム |
US7010391B2 (en) | 2001-03-28 | 2006-03-07 | Handylab, Inc. | Methods and systems for control of microfluidic devices |
ES2244549T3 (es) * | 2001-04-12 | 2005-12-16 | Siemens Aktiengesellschaft | Procedimiento para la facturacion de servicios en una red de comunicaciones. |
US20040142496A1 (en) * | 2001-04-23 | 2004-07-22 | Nicholson Jeremy Kirk | Methods for analysis of spectral data and their applications: atherosclerosis/coronary heart disease |
JP2004536631A (ja) | 2001-05-03 | 2004-12-09 | マサチューセッツ・アイ・アンド・イア・インファーマリー | 移植可能な薬物送達デバイスおよびその使用 |
US20030211618A1 (en) | 2001-05-07 | 2003-11-13 | Patel Gordhandhai Nathalal | Color changing steam sterilization indicator |
IL158788A0 (en) | 2001-05-09 | 2004-05-12 | Axis Shield Asa | Assay system |
US6591124B2 (en) | 2001-05-11 | 2003-07-08 | The Procter & Gamble Company | Portable interstitial fluid monitoring system |
US20050009101A1 (en) * | 2001-05-17 | 2005-01-13 | Motorola, Inc. | Microfluidic devices comprising biochannels |
EP1399059B1 (en) | 2001-05-18 | 2006-08-30 | Polymer Technology Systems, Inc. | Body fluid test apparatus with detachably mounted portable tester |
US6919046B2 (en) | 2001-06-07 | 2005-07-19 | Nanostream, Inc. | Microfluidic analytical devices and methods |
US6767341B2 (en) * | 2001-06-13 | 2004-07-27 | Abbott Laboratories | Microneedles for minimally invasive drug delivery |
JP2002371955A (ja) | 2001-06-15 | 2002-12-26 | Sanuki Kogyo Kk | 往復駆動装置及び該装置を使用した送液ポンプ |
US20030208113A1 (en) | 2001-07-18 | 2003-11-06 | Mault James R | Closed loop glycemic index system |
US20030117491A1 (en) * | 2001-07-26 | 2003-06-26 | Dov Avni | Apparatus and method for controlling illumination in an in-vivo imaging device |
AU2002367840A1 (en) | 2001-07-26 | 2003-11-17 | Motorola, Inc. | System and methods for mixing within a microfluidic device |
WO2003014735A1 (en) * | 2001-08-03 | 2003-02-20 | General Hospital Corporation | System, process and diagnostic arrangement establishing and monitoring medication doses for patients |
JP3775263B2 (ja) | 2001-08-10 | 2006-05-17 | ニプロ株式会社 | 記録媒体およびこの記録媒体を用いた血糖測定システム |
US6823283B2 (en) * | 2001-08-14 | 2004-11-23 | National Instruments Corporation | Measurement system including a programmable hardware element and measurement modules that convey interface information |
US6751491B2 (en) | 2001-09-01 | 2004-06-15 | M Biotech Inc | Analyte measuring biosensor chip using image scanning system |
WO2003021853A2 (en) * | 2001-09-05 | 2003-03-13 | Genicon Sciences Corporation | Apparatus for reading signals generated from resonance light scattered particle labels |
US6966880B2 (en) * | 2001-10-16 | 2005-11-22 | Agilent Technologies, Inc. | Universal diagnostic platform |
JP2003222611A (ja) | 2001-11-20 | 2003-08-08 | Nec Corp | 分離装置、分離方法および分離装置の製造方法 |
US7635588B2 (en) | 2001-11-29 | 2009-12-22 | Applied Biosystems, Llc | Apparatus and method for differentiating multiple fluorescence signals by excitation wavelength |
JP2003166910A (ja) | 2001-11-30 | 2003-06-13 | Asahi Kasei Corp | 送液機構及び該送液機構を備える分析装置 |
JP2003167960A (ja) | 2001-12-04 | 2003-06-13 | Ikuo Kondo | 健康管理システム |
GB0129816D0 (en) * | 2001-12-13 | 2002-01-30 | The Technology Partnership Plc | Testing device for chemical or biochemical analysis |
US7457731B2 (en) | 2001-12-14 | 2008-11-25 | Siemens Medical Solutions Usa, Inc. | Early detection of disease outbreak using electronic patient data to reduce public health threat from bio-terrorism |
AU2002357002A1 (en) * | 2001-12-17 | 2003-06-30 | Powderject Research Limited | Diagnostic sensing apparatus |
KR100491144B1 (ko) * | 2001-12-26 | 2005-05-24 | 삼성에스디아이 주식회사 | 평판표시장치 및 그의 제조방법 |
US20050027182A1 (en) | 2001-12-27 | 2005-02-03 | Uzair Siddiqui | System for monitoring physiological characteristics |
JP2003207454A (ja) | 2002-01-15 | 2003-07-25 | Minolta Co Ltd | 透過光検出装置 |
FI112093B (fi) | 2002-01-30 | 2003-10-31 | Boreal Plant Breeding Ltd | Menetelmä ja testipakkaus geneettisen identiteetin osoittamiseksi |
US20030143551A1 (en) | 2002-01-30 | 2003-07-31 | Cattell Herbert F. | Reading multiple chemical arrays |
US20040109793A1 (en) | 2002-02-07 | 2004-06-10 | Mcneely Michael R | Three-dimensional microfluidics incorporating passive fluid control structures |
US20030148362A1 (en) | 2002-02-07 | 2003-08-07 | Eastern Virginia Medical School Of The Medical College Of Hampton Roads | Diagnostic microarray and method of use thereof |
US7004928B2 (en) | 2002-02-08 | 2006-02-28 | Rosedale Medical, Inc. | Autonomous, ambulatory analyte monitor or drug delivery device |
US20030212379A1 (en) * | 2002-02-26 | 2003-11-13 | Bylund Adam David | Systems and methods for remotely controlling medication infusion and analyte monitoring |
CA2419200C (en) | 2002-03-05 | 2015-06-30 | Bayer Healthcare Llc | Fluid collection apparatus having an integrated lance and reaction area |
US20040122486A1 (en) * | 2002-12-18 | 2004-06-24 | Stahmann Jeffrey E. | Advanced patient management for acquiring, trending and displaying health-related parameters |
WO2003085379A2 (en) | 2002-04-01 | 2003-10-16 | Fluidigm Corporation | Microfluidic particle-analysis systems |
US6787108B2 (en) | 2002-04-02 | 2004-09-07 | Cmc Daymark Corporation | Plural intrinsic expiration initiation application indicators |
US7797033B2 (en) * | 2002-04-08 | 2010-09-14 | Smart Pill Corporation | Method of using, and determining location of, an ingestible capsule |
US6832296B2 (en) | 2002-04-09 | 2004-12-14 | Ip-First, Llc | Microprocessor with repeat prefetch instruction |
JP2003315348A (ja) | 2002-04-22 | 2003-11-06 | Hitachi High-Technologies Corp | 検体処理システム及びそれを用いた検体検査自動化システム |
US7112444B2 (en) | 2002-04-24 | 2006-09-26 | Wisconsin Alumni Research Foundation | Method of performing gradient-based assays in a microfluidic device |
WO2003090614A1 (fr) | 2002-04-25 | 2003-11-06 | Matsushita Electric Industrial Co., Ltd. | Dispositif de determination de dose, injecteur et systeme de gestion sanitaire |
AU2003235968A1 (en) * | 2002-04-30 | 2003-11-17 | Arkray, Inc. | Analytical instrument |
JP2003322653A (ja) | 2002-05-07 | 2003-11-14 | Toshiba Corp | プローブ固定支持体及びプローブ固定担体 |
US6883957B2 (en) | 2002-05-08 | 2005-04-26 | Cytonome, Inc. | On chip dilution system |
US20030143113A2 (en) | 2002-05-09 | 2003-07-31 | Lifescan, Inc. | Physiological sample collection devices and methods of using the same |
JP4855680B2 (ja) * | 2002-05-09 | 2012-01-18 | ザ・ユニバーシティ・オブ・シカゴ | 圧力駆動プラグによる輸送と反応のための装置および方法 |
US7125510B2 (en) | 2002-05-15 | 2006-10-24 | Zhili Huang | Microstructure fabrication and microsystem integration |
JP3839349B2 (ja) | 2002-05-15 | 2006-11-01 | 株式会社堀場製作所 | 化学発光酵素免疫測定装置 |
US7303921B2 (en) * | 2002-05-23 | 2007-12-04 | Gian Paolo Littarru | Method to assay coenzyme Q10 in blood plasma or blood serum |
JP2005529327A (ja) | 2002-06-11 | 2005-09-29 | ケムパック エイ/エス | 液体中に懸濁された粒子を特徴付けるための使い捨てカートリッジ |
JP4106977B2 (ja) | 2002-06-21 | 2008-06-25 | 株式会社日立製作所 | 分析チップ及び分析装置 |
EP1376131A1 (en) * | 2002-06-27 | 2004-01-02 | Inverness Medical Switzerland GmbH | Assay device for liquid sample |
US20040005247A1 (en) | 2002-07-03 | 2004-01-08 | Nanostream, Inc. | Microfluidic closed-end metering systems and methods |
US7470533B2 (en) | 2002-12-20 | 2008-12-30 | Acea Biosciences | Impedance based devices and methods for use in assays |
US7840421B2 (en) | 2002-07-31 | 2010-11-23 | Otto Carl Gerntholtz | Infectious disease surveillance system |
WO2004014227A1 (en) | 2002-08-13 | 2004-02-19 | Given Imaging Ltd. | System for in vivo sampling and analysis |
CN2559986Y (zh) | 2002-08-23 | 2003-07-09 | 上海博昇微晶科技有限公司 | 集成微流体和微阵列探针的微芯片 |
US7188731B2 (en) | 2002-08-26 | 2007-03-13 | The Regents Of The University Of California | Variable flexure-based fluid filter |
JP2004101381A (ja) | 2002-09-10 | 2004-04-02 | Nittec Co Ltd | 自動分析装置用の複光路セル及びこの複光路セルを用いた分析方法 |
US20040047767A1 (en) * | 2002-09-11 | 2004-03-11 | Richard Bergman | Microfluidic channel for band broadening compensation |
US7282328B2 (en) | 2002-09-20 | 2007-10-16 | New England Biolabs, Inc. | Helicase dependent amplification of nucleic acids |
US7186383B2 (en) * | 2002-09-27 | 2007-03-06 | Ast Management Inc. | Miniaturized fluid delivery and analysis system |
TW590982B (en) * | 2002-09-27 | 2004-06-11 | Agnitio Science & Technology I | Micro-fluid driving device |
US7807197B2 (en) | 2002-09-28 | 2010-10-05 | Mcneil-Ppc, Inc. | Composite dosage forms having an inlaid portion |
US20040064528A1 (en) * | 2002-09-30 | 2004-04-01 | Microsoft Corporation | Safe interoperability among web services |
US7177767B2 (en) | 2002-10-18 | 2007-02-13 | Abaxis, Inc. | Systems and methods for the detection of short and long samples |
US20040086872A1 (en) | 2002-10-31 | 2004-05-06 | Childers Winthrop D. | Microfluidic system for analysis of nucleic acids |
US7390457B2 (en) | 2002-10-31 | 2008-06-24 | Agilent Technologies, Inc. | Integrated microfluidic array device |
US20040157336A1 (en) * | 2002-11-14 | 2004-08-12 | Affymetrix, Inc. | Automated fluid control system and process |
US20040121305A1 (en) * | 2002-12-18 | 2004-06-24 | Wiegand Roger Charles | Generation of efficacy, toxicity and disease signatures and methods of use thereof |
CN1173182C (zh) | 2002-12-18 | 2004-10-27 | 陕西超英生物医学研究开发有限公司 | 糖尿病自身免疫抗体检测蛋白芯片、其制备及检测方法 |
US20060094108A1 (en) | 2002-12-20 | 2006-05-04 | Karl Yoder | Thermal cycler for microfluidic array assays |
CN102620959B (zh) | 2002-12-26 | 2015-12-16 | 梅索磅秤技术有限公司 | 检定盒及其使用方法 |
US20050221281A1 (en) | 2003-01-08 | 2005-10-06 | Ho Winston Z | Self-contained microfluidic biochip and apparatus |
US7122153B2 (en) | 2003-01-08 | 2006-10-17 | Ho Winston Z | Self-contained microfluidic biochip and apparatus |
US7419638B2 (en) * | 2003-01-14 | 2008-09-02 | Micronics, Inc. | Microfluidic devices for fluid manipulation and analysis |
DE10307030A1 (de) | 2003-02-20 | 2004-09-09 | Eppendorf Ag | Dosiersystem |
US20040176704A1 (en) * | 2003-03-04 | 2004-09-09 | Stevens Timothy A | Collection device adapted to accept cartridge for point of care system |
SE0300823D0 (sv) | 2003-03-23 | 2003-03-23 | Gyros Ab | Preloaded Microscale Devices |
JP4464172B2 (ja) | 2003-03-31 | 2010-05-19 | キヤノン株式会社 | 生化学反応カートリッジ及びその使用方法 |
US7178386B1 (en) * | 2003-04-10 | 2007-02-20 | Nanostream, Inc. | Parallel fluid processing systems and methods |
US7415299B2 (en) * | 2003-04-18 | 2008-08-19 | The Regents Of The University Of California | Monitoring method and/or apparatus |
US7611480B2 (en) | 2003-04-24 | 2009-11-03 | Levy Mark M | Gastrointestinal bioreactor |
US20060206010A1 (en) | 2003-05-09 | 2006-09-14 | Nec Corporation | Diagnostic support system and mobile terminal |
JP4260541B2 (ja) | 2003-05-12 | 2009-04-30 | 旭化成ファーマ株式会社 | 糖化タンパク質測定用試験片 |
US20040228765A1 (en) | 2003-05-14 | 2004-11-18 | Witty Thomas R. | Point of care diagnostic platform |
US20040228766A1 (en) | 2003-05-14 | 2004-11-18 | Witty Thomas R. | Point of care diagnostic platform |
US6789510B1 (en) * | 2003-05-30 | 2004-09-14 | Ru-Ping Lee | Animal restraining apparatus and animal experiment for using the same |
US20040241048A1 (en) | 2003-05-30 | 2004-12-02 | Applera Corporation | Thermal cycling apparatus and method for providing thermal uniformity |
US7258673B2 (en) | 2003-06-06 | 2007-08-21 | Lifescan, Inc | Devices, systems and methods for extracting bodily fluid and monitoring an analyte therein |
EP1637881B1 (en) | 2003-06-20 | 2012-05-02 | Universal Bio Research Co., Ltd. | Sample arraying/assembling device, its method, and apparatus using sample assembly |
JP3918178B2 (ja) | 2003-06-23 | 2007-05-23 | 大阪瓦斯株式会社 | 高純度ナノスケールカーボンチューブ含有炭素質材料の製造法 |
US20050009191A1 (en) | 2003-07-08 | 2005-01-13 | Swenson Kirk D. | Point of care information management system |
JP2005030983A (ja) | 2003-07-09 | 2005-02-03 | Matsushita Electric Ind Co Ltd | 測定装置 |
EP1650570B1 (en) | 2003-07-17 | 2021-05-26 | LSI Medience Corporation | Apparatus for use in measuring a component contained in a sample comprising a measuring device and a cartridge |
US7860727B2 (en) | 2003-07-17 | 2010-12-28 | Ventana Medical Systems, Inc. | Laboratory instrumentation information management and control network |
US8346482B2 (en) | 2003-08-22 | 2013-01-01 | Fernandez Dennis S | Integrated biosensor and simulation system for diagnosis and therapy |
WO2005084534A1 (en) | 2003-09-03 | 2005-09-15 | Life Patch International, Inc. | Personal diagnostic devices and related methods |
WO2005024437A1 (ja) * | 2003-09-05 | 2005-03-17 | Nec Corporation | 測定システム |
US7682833B2 (en) * | 2003-09-10 | 2010-03-23 | Abbott Point Of Care Inc. | Immunoassay device with improved sample closure |
KR101330431B1 (ko) * | 2003-09-11 | 2013-11-20 | 테라노스, 인코포레이티드 | 피분석물의 모니터링 및 약물 전달을 위한 의료 기기 |
JP4933258B2 (ja) | 2003-09-22 | 2012-05-16 | クイデル コーポレーション | 試料中の複数分析物の検出装置 |
US7524464B2 (en) | 2003-09-26 | 2009-04-28 | Ahn Chong H | Smart disposable plastic lab-on-a-chip for point-of-care testing |
JP2005104750A (ja) | 2003-09-29 | 2005-04-21 | Matsushita Electric Ind Co Ltd | ナノチューブの精製方法 |
JP4441618B2 (ja) | 2003-10-06 | 2010-03-31 | 独立行政法人産業技術総合研究所 | インフルエンザウイルスの検出方法 |
JP4073023B2 (ja) | 2003-11-07 | 2008-04-09 | 財団法人新産業創造研究機構 | 微小流路デバイスおよびその作製方法 |
US8615282B2 (en) | 2004-07-13 | 2013-12-24 | Dexcom, Inc. | Analyte sensor |
KR20050049656A (ko) * | 2003-11-22 | 2005-05-27 | 엘지.필립스 엘시디 주식회사 | 액정표시패널 및 그 제조방법 |
GB0329288D0 (en) | 2003-12-18 | 2004-01-21 | Inverness Medical Switzerland | Monitoring method and apparatus |
WO2005065157A2 (en) * | 2003-12-23 | 2005-07-21 | Fastraq, Inc. | Point of care diagnostic platform |
CA2554007C (en) | 2004-01-27 | 2013-03-26 | Altivera L.L.C. | Diagnostic radio frequency identification sensors and applications thereof |
US7105183B2 (en) | 2004-02-03 | 2006-09-12 | The Regents Of The University Of California | Chlorite in the treatment of neurodegenerative disease |
US20050177057A1 (en) * | 2004-02-05 | 2005-08-11 | Mitchell Friedman | Automated breath collection device |
US20060257941A1 (en) * | 2004-02-27 | 2006-11-16 | Mcdevitt John T | Integration of fluids and reagents into self-contained cartridges containing particle and membrane sensor elements |
JP2005291954A (ja) | 2004-03-31 | 2005-10-20 | Olympus Corp | 使い捨て試薬パックとその試薬パックを用いる分析装置 |
US7887750B2 (en) | 2004-05-05 | 2011-02-15 | Bayer Healthcare Llc | Analytical systems, devices, and cartridges therefor |
US8323564B2 (en) * | 2004-05-14 | 2012-12-04 | Honeywell International Inc. | Portable sample analyzer system |
EP1766400B1 (en) * | 2004-06-03 | 2009-04-15 | Meso Scale Technologies, LLC | Methods for conducting whole blood assays |
EP1761645A4 (en) | 2004-06-10 | 2008-12-31 | Agency Science Tech & Res | DIAGNOSTIC PRIMERS AND METHOD FOR DETECTING H5 AND H5N1 SUBTYPES OF AVIAN INFLUENZA VIRUS |
US20060036619A1 (en) | 2004-08-09 | 2006-02-16 | Oren Fuerst | Method for accessing and analyzing medically related information from multiple sources collected into one or more databases for deriving illness probability and/or for generating alerts for the detection of emergency events relating to disease management including HIV and SARS, and for syndromic surveillance of infectious disease and for predicting risk of adverse events to one or more drugs |
CN1311239C (zh) | 2004-09-07 | 2007-04-18 | 李人 | 免疫层析测试条及其制造方法 |
EP1794581A2 (en) | 2004-09-15 | 2007-06-13 | Microchip Biotechnologies, Inc. | Microfluidic devices |
EP1805500A4 (en) | 2004-09-28 | 2008-05-07 | Singulex Inc | SYSTEM AND METHOD FOR THE SPECTROSCOPIC ANALYSIS OF INDIVIDUAL PARTICLES |
EP1817708A4 (en) | 2004-10-18 | 2014-08-27 | Wellstat Vaccines Llc | SYSTEMS AND METHODS FOR OBTAINING, STORING, PROCESSING AND USING IMMUNOLOGICAL INFORMATION RELATING TO AN INDIVIDUAL OR A POPULATION |
US7604985B2 (en) | 2004-11-10 | 2009-10-20 | Becton, Dickinson And Company | System and method for determining fill volume in a container |
CA2588230A1 (en) | 2004-11-23 | 2006-08-10 | Response Biomedical Corporation | Immunoassay employing two-step internal calibration reaction |
US7396689B2 (en) * | 2005-02-04 | 2008-07-08 | Decision Biomarkers Incorporated | Method of adjusting the working range of a multi-analyte assay |
WO2006087574A2 (en) | 2005-02-19 | 2006-08-24 | Geneform Technologies Limited | Isothermal nucleic acid amplification |
GB0503836D0 (en) | 2005-02-24 | 2005-04-06 | Axis Shield Asa | Method |
WO2006116455A2 (en) | 2005-04-26 | 2006-11-02 | Applera Corporation | System for genetic surveillance and analysis |
EP2392258B1 (en) | 2005-04-28 | 2014-10-08 | Proteus Digital Health, Inc. | Pharma-informatics system |
CA2607661C (en) | 2005-05-09 | 2017-08-08 | Idaho Technology, Inc. | A device and method for two-stage nucleic acid amplification |
US7888125B2 (en) * | 2005-05-09 | 2011-02-15 | Theranos, Inc. | Calibration of fluidic devices |
JP4520359B2 (ja) | 2005-05-13 | 2010-08-04 | 日立ソフトウエアエンジニアリング株式会社 | 粒子捕捉装置、並びに粒子配列方法及び粒子配列装置 |
US8020110B2 (en) * | 2005-05-26 | 2011-09-13 | Weisermazars Llp | Methods for defining queries, generating query results and displaying same |
US20070031283A1 (en) | 2005-06-23 | 2007-02-08 | Davis Charles Q | Assay cartridges and methods for point of care instruments |
EA200501118A1 (ru) | 2005-07-13 | 2006-08-25 | Давид Георгиевич Хидашели | Способ и система анализа характеристик жидких сред биологических организмов |
US20070118399A1 (en) | 2005-11-22 | 2007-05-24 | Avinash Gopal B | System and method for integrated learning and understanding of healthcare informatics |
EP1963866B1 (en) * | 2005-12-22 | 2018-05-16 | Honeywell International Inc. | Hematological analyzer system with removable cartridge |
EP1971771A1 (fr) * | 2006-01-12 | 2008-09-24 | Nheolis (Sarl) | Aerogenerateur a axe horizontal |
WO2007092713A2 (en) | 2006-02-02 | 2007-08-16 | Trustees Of The University Of Pennsylvania | Microfluidic system and method for analysis of gene expression in cell-containing samples and detection of disease |
EA013659B1 (ru) | 2006-03-10 | 2010-06-30 | Хадас Леви | Автоматизированный отбор проб и их анализ с использованием персонального пробоотборника-анализатора |
US8741230B2 (en) | 2006-03-24 | 2014-06-03 | Theranos, Inc. | Systems and methods of sample processing and fluid control in a fluidic system |
WO2007120904A2 (en) | 2006-04-14 | 2007-10-25 | Fuzzmed, Inc. | System, method, and device for personal medical care, intelligent analysis, and diagnosis |
US8007999B2 (en) | 2006-05-10 | 2011-08-30 | Theranos, Inc. | Real-time detection of influenza virus |
US9015055B2 (en) | 2006-07-13 | 2015-04-21 | Abbott Point Of Care Inc. | Medical data acquisition and patient management system and method |
US7674616B2 (en) | 2006-09-14 | 2010-03-09 | Hemosense, Inc. | Device and method for measuring properties of a sample |
US20080113391A1 (en) | 2006-11-14 | 2008-05-15 | Ian Gibbons | Detection and quantification of analytes in bodily fluids |
US20090137047A1 (en) | 2007-03-02 | 2009-05-28 | John Frederick Regan | Automated Diagnostic Kiosk for Diagnosing Diseases |
US20080243394A1 (en) | 2007-03-27 | 2008-10-02 | Theranostics Llc | System, method and computer program product for manipulating theranostic assays |
DK2152417T3 (en) * | 2007-05-04 | 2018-08-06 | Opko Diagnostics Llc | APPARATUS AND PROCEDURE FOR ANALYSIS IN MICROFLUID SYSTEMS |
US8158430B1 (en) | 2007-08-06 | 2012-04-17 | Theranos, Inc. | Systems and methods of fluidic sample processing |
SG10201606120XA (en) | 2007-10-02 | 2016-09-29 | Theranos Inc | Modular Point-Of-Care Devices And Uses Thereof |
AU2009222181B2 (en) | 2008-02-29 | 2014-12-04 | Northwestern University | Barriers for facilitating biological reactions |
JP5511095B2 (ja) | 2008-03-20 | 2014-06-04 | アバクシス, インコーポレイテッド | ゾル粒子特異的結合アッセイの多波長分析 |
SG177936A1 (en) | 2008-03-26 | 2012-02-28 | Theranos Inc | Methods and systems for assessing clinical outcomes |
US9779213B2 (en) | 2008-07-25 | 2017-10-03 | Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud | System for evaluating a pathological stage of prostate cancer |
US8263006B2 (en) * | 2009-05-31 | 2012-09-11 | Corning Incorporated | Reactor with upper and lower manifold structures |
US20110213619A1 (en) | 2010-02-26 | 2011-09-01 | Henke Tom L | Method and system for online medical diagnosis |
US20110213564A1 (en) | 2010-02-26 | 2011-09-01 | Henke Tom L | Method and apparatus for code verified testing |
US20110213579A1 (en) | 2010-02-26 | 2011-09-01 | Henke Tom L | Method and apparatus for verifying test results |
WO2011106512A1 (en) | 2010-02-26 | 2011-09-01 | Quickcheck Health, Inc. | Method and apparatus for code verified testing |
UY33627A (es) | 2010-09-24 | 2013-04-30 | Array Biopharma Inc | Compuestos para tratar enfermedades neurodegenerativas |
EP2646153B1 (en) | 2010-12-03 | 2019-05-01 | Abbott Point of Care Inc. | Sample metering device and assay device with integrated sample dilution |
US9619627B2 (en) | 2011-09-25 | 2017-04-11 | Theranos, Inc. | Systems and methods for collecting and transmitting assay results |
US8380541B1 (en) | 2011-09-25 | 2013-02-19 | Theranos, Inc. | Systems and methods for collecting and transmitting assay results |
US20130080071A1 (en) | 2011-09-25 | 2013-03-28 | Theranos, Inc., a Delaware Corporation | Systems and methods for sample processing and analysis |
WO2013043204A1 (en) | 2011-09-25 | 2013-03-28 | Theranos, Inc. | Systems and methods for collecting and transmitting assay results |
US20140335505A1 (en) | 2011-09-25 | 2014-11-13 | Theranos, Inc. | Systems and methods for collecting and transmitting assay results |
US10828636B2 (en) | 2016-10-25 | 2020-11-10 | Fannin Partners Llc | Automated remotely instructed driving of an assay |
-
2006
- 2006-03-24 US US11/388,824 patent/US7888125B2/en active Active
- 2006-03-24 KR KR1020177020579A patent/KR101931899B1/ko active IP Right Grant
- 2006-03-24 MX MX2015003930A patent/MX340077B/es unknown
- 2006-03-24 US US11/389,409 patent/US7635594B2/en active Active
- 2006-03-24 KR KR1020157008967A patent/KR101637140B1/ko active IP Right Grant
- 2006-03-24 US US11/388,823 patent/US8841076B2/en active Active
- 2006-03-24 KR KR1020137005225A patent/KR101392106B1/ko active IP Right Grant
- 2006-03-24 WO PCT/US2006/011090 patent/WO2006121510A2/en active Application Filing
- 2006-03-24 KR KR1020167017039A patent/KR101762424B1/ko active IP Right Grant
- 2006-03-24 NZ NZ60361306A patent/NZ603613A/en not_active IP Right Cessation
- 2006-03-24 US US11/389,410 patent/US20060264783A1/en not_active Abandoned
- 2006-03-24 CA CA3209322A patent/CA3209322A1/en active Pending
- 2006-03-24 MX MX2007013985A patent/MX2007013985A/es active IP Right Grant
- 2006-03-24 CN CN200680024658.XA patent/CN101535499B/zh active Active
- 2006-03-24 AU AU2006244617A patent/AU2006244617B2/en active Active
- 2006-03-24 ES ES06748733T patent/ES2820430T3/es active Active
- 2006-03-24 NZ NZ620811A patent/NZ620811A/en not_active IP Right Cessation
- 2006-03-24 NZ NZ59093006A patent/NZ590930A/xx not_active IP Right Cessation
- 2006-03-24 KR KR1020117006832A patent/KR101322943B1/ko active IP Right Grant
- 2006-03-24 KR KR1020137027526A patent/KR101569265B1/ko active IP Right Grant
- 2006-03-24 NZ NZ564141A patent/NZ564141A/en not_active IP Right Cessation
- 2006-03-24 US US11/388,723 patent/US20060264779A1/en not_active Abandoned
- 2006-03-24 KR KR1020077028881A patent/KR101381331B1/ko active IP Right Grant
- 2006-03-24 KR KR1020147019652A patent/KR101569307B1/ko active IP Right Grant
- 2006-03-24 NZ NZ60360406A patent/NZ603604A/en not_active IP Right Cessation
- 2006-03-24 JP JP2008511111A patent/JP2008544214A/ja not_active Withdrawn
- 2006-03-24 DE DE20190164.2T patent/DE20190164T1/de active Pending
- 2006-03-24 NZ NZ59952206A patent/NZ599522A/xx not_active IP Right Cessation
- 2006-03-24 US US11/388,415 patent/US8679407B2/en active Active
- 2006-03-24 EP EP20190164.2A patent/EP3763824A1/en active Pending
- 2006-03-24 CA CA2610294A patent/CA2610294C/en active Active
- 2006-03-24 EP EP06748733.0A patent/EP1883341B1/en active Active
-
2007
- 2007-11-08 MX MX2021011543A patent/MX2021011543A/es unknown
- 2007-11-08 IL IL187272A patent/IL187272A/en active IP Right Grant
-
2009
- 2009-10-08 US US12/576,197 patent/US8283155B2/en active Active
- 2009-11-24 US US12/625,430 patent/US9075046B2/en active Active
-
2011
- 2011-01-07 US US12/986,954 patent/US9182388B2/en active Active
- 2011-10-31 US US13/286,168 patent/US20120052561A1/en not_active Abandoned
-
2012
- 2012-03-30 JP JP2012081306A patent/JP2012127978A/ja active Pending
- 2012-10-08 US US13/647,325 patent/US20130115685A1/en active Pending
- 2012-10-30 JP JP2012238759A patent/JP2013029525A/ja active Pending
-
2013
- 2013-11-14 US US14/080,727 patent/US20140222447A1/en not_active Abandoned
-
2014
- 2014-05-11 IL IL232544A patent/IL232544A/en active IP Right Grant
- 2014-09-09 US US14/481,264 patent/US10761030B2/en active Active
-
2015
- 2015-04-27 JP JP2015089978A patent/JP2015158507A/ja active Pending
- 2015-04-27 JP JP2015089977A patent/JP2015158506A/ja not_active Withdrawn
- 2015-06-01 US US14/727,547 patent/US9772291B2/en active Active
- 2015-09-28 US US14/867,271 patent/US10908093B2/en active Active
-
2017
- 2017-04-24 JP JP2017085342A patent/JP2017142265A/ja active Pending
- 2017-07-24 IL IL253639A patent/IL253639B2/en unknown
- 2017-08-29 US US15/689,905 patent/US11630069B2/en active Active
-
2018
- 2018-04-12 US US15/951,659 patent/US20180231469A1/en active Pending
-
2019
- 2019-09-02 JP JP2019159417A patent/JP2019219416A/ja not_active Withdrawn
- 2019-09-09 JP JP2019163674A patent/JP2019219420A/ja active Pending
-
2020
- 2020-08-31 US US17/007,334 patent/US20210055226A1/en active Pending
-
2021
- 2021-02-01 US US17/164,032 patent/US20210262940A1/en active Pending
- 2021-09-15 JP JP2021150185A patent/JP2021193390A/ja active Pending
-
2023
- 2023-04-17 US US18/301,835 patent/US20240085338A1/en active Pending
- 2023-10-02 JP JP2023171310A patent/JP2023169427A/ja active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5961451A (en) * | 1997-04-07 | 1999-10-05 | Motorola, Inc. | Noninvasive apparatus having a retaining member to retain a removable biosensor |
US20020120183A1 (en) * | 2001-02-15 | 2002-08-29 | Klaus Abraham-Fuchs | Network for evaluating data obtained in a biochip measurement device |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101535499B (zh) | 点护理流体系统及其应用 | |
AU2013201509B2 (en) | Point-of-care fluidic systems and uses thereof | |
AU2017245443A1 (en) | Point-of-care fluidic systems and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1136316 Country of ref document: HK |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180125 Address after: American California Patentee after: Serranos intellectual property limited liability company Address before: American California Patentee before: Theranos, Inc. |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1136316 Country of ref document: HK |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: Delaware, USA Patentee after: Labrador diagnostics Ltd Address before: California, USA Patentee before: THERANOS, Inc. |